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Abstract: We report a new one-pot synthesis of 2-trifluoromethylated/2-perfluoroalkylated
N-aryl-substituted pyridiniums, 5,6,7,8-tetrahydroquinoliniums and 6,7,8,9-tetrahydro-5H-
cyclohepta[b]-pyridinium compounds starting from an activated β-dicarbonyl analogue (here
a perfluoro-alkylated gem-iodoacetoxy derivative), an aromatic amine and a (cyclic or acyclic)
ketone. The key step of this multicomponent reaction, involves the formation of a 3-perfluoroalkyl-
N,N’-diaryl-1,5-diazapentadiene intermediate, various examples of which were isolated and
characterized for the first time, together with investigation of their reactivity. We propose a
mechanism involving a concurrent inverse electron demand Diels-Alder or Aza-Robinson cascade
cyclisation, followed by a bis-de-anilino-elimination. Noteworthy, a meta-methoxy substituent on
the aniline directs the reaction towards a 2-perfluoroalkyl-7-methoxyquinoline, resulting from the
direct cyclization of the diazapentadiene intermediate, instead of pyridinium formation. This is the
first evidence of synthesis of pyridinium derivatives from activated β-dicarbonyls, ketones, and an
aromatic amine, the structures of which (both reactants and products) being analogous to species
involved in biological systems, especially upon neurodegenerative diseases such as Parkinson’s.
Beyond suggesting chemical/biochemical analogies, we thus hope to outline new research directions
for understanding the mechanism of in vivo formation of pyridiniums, hence possible pharmaceutical
strategies to better monitor, control or prevent it.
Keywords: N-arylpyridinium; Parkinsonism; IEDDA; aza-Robinson; N-aryl-tetrahydro-quinoliniums;
N-aryl-tetrahydro-5H-cyclohepta[b]pyridiniums; bis-anilino-tetrahydropyridine; multicomponent reaction
1. Introduction
Compounds containing a pyridinium moiety are important in natural product chemistry [1–4]
and in organic synthesis [5–7]. The presence of various substituents, either on the pyridine ring or at
the nitrogen atom of the ring, make these important scaffolds versatile compounds used in various
areas, ranging from pharmaceutical to industrial chemical applications.
Pyridinium compounds are generally employed as acylating agents [8], phase transfer catalysts [9],
dyes [1] and cationic surfactants [9]. 1-Alkylpyridinium derivatives which are liquid at rt., so-called
ionic liquids, are potential new solvents for synthesis and catalysis [5]. Pyridinium compounds have
been also used to achieve asymmetric and regioselective synthesis by additions of Grignard reagent [10].
Moreover, pyridinium compounds are widely applied as synthetic building blocks to obtain substituted
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pyridines, dihydropyridines or piperidines [11]. Other N-methyl-pyridinium derivatives have been
investigated as new materials, for example, to allow ionic bonding necessary for molecular packing in
self-organized solids [12].
On the other hand, quaternary pyridinium derivatives are unsaturated heterocyclic surfactants,
generally known for their germicidal properties with a wide range of antimicrobial activity [13–15],
as well as against some pathogenic species of fungi and protozoa [16].
Also, it was reported that quaternary ammonium compounds react with cell walls and have a
direct or indirect lethal effect on the cell [17]. Related quaternary pyridinium derivatives have been
tested for anticancer [18], and anti-malarial activity [19,20], and as cholinesterase inhibitors for the
treatment of Alzheimer’s disease [21–23].
Moreover, pyridinium ions have been incorporated in drug candidates to improve their water
solubility [24–26]. Otherwise, the use of pyridinium ions bearing lipophilic groups has been shown to
improve their accumulation in mitochondria to scavenge or detect radicals generated there [27,28].
Recently, pyridinium amphiphiles were shown to generate promising transfection systems
for gene therapy [29–32]. Several supramolecular pyridinium containing complexes proved to be
extremely efficient nucleic acid delivery systems, displaying excellent serum stability and tissue
penetration [30,32].
The association of pyridinium derivatives with the appearance of Parkinson’s disease, led to
a search for pyridinium analogs as possible endogenous or exogenous neurotoxins critical to this
neurodegeneration [33]. For example, 1-methyl-4-phenylpyridinium (MPP+) 1 is the most popular
molecule used to induce Parkinsonism in vivo (Scheme 1) [34–36]. More recently, pyridinium
furosemide (PF) 2, has been also used as a model in helping to identify specific events of Parkinson’s
disease [37].
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Scheme 1. Structure of 1-methyl-4-phenylpyridinium (MPP+) 1 and pyridinium furosemide 2 
correlated to neurodegeneration. 
Besides, pyridinium containing compounds are used as herbicides [38,39], drugs [13–32], and as 
intermediates in the synthesis of many heterocyclic compounds [1–7,11] and are considered as 
possible exogenous neurotoxins [40–42]. However, several lines of evidence suggest that pyridinium 
derivatives may be formed under endogenous conditions [43], for example during the Maillard 
reaction between proteins and carbonyl compounds [43–45].  
Synthesis of Pyridinium Compounds—A Short Literature Survey 
The best-known method for the synthesis of N-(hetero)arylpyridinium salts is the Zincke amine 
exchange reaction [46–50], which requires a two-step procedure (Scheme 2): First a pyridine 3 is 
reacted with 1-chloro-2,4-dinitrobenzene (4, X = Cl) to give an N-(2,4-dinitrophenyl)pyridinium 
chloride 5. This highly electrophilic compound 5 is then reacted with an (hetero)arylamine to give a 
new N-(hetero)arylpyridinium salt 6 with elimination of 2,4-dinitroaniline [46–50]. This reaction will 
work best if R is an electron-donor substituent.  
Besides, several synthetic routes to N-alkylpyridinium compounds 7 are known, but the most 
commonly used method is the Menschutkin reaction, an SN2 reaction of a pyridine derivative 3 with 
an alkyl halide or sulfonate (R’-X) (Scheme 2) [51,52]. This reaction is favored by electron-donor 
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Besides, pyridiniu containing co pounds are used as herbicides [38,39], drugs [13–32], and as
intermediates in the synthesis of many heterocyclic compounds [1–7,11] and are considered as possible
exogenous neurotoxins [40–42]. However, several lines of evidence suggest that pyridinium derivatives
may be formed under endogenous conditions [43], for example during the Maillard reaction between
proteins and carbonyl compounds [43–45].
Synthesis of Pyridinium Compounds—A Short Literature Survey
The best-known method for the synthesis of N-(hetero)arylpyridinium salts is the Zincke amine
exchange reaction [46–50], which requires a two-step procedure (Scheme 2): First a pyridine 3 is reacted
with 1-chloro-2,4-dinitrobenzene (4, X = Cl) to give an N-(2,4-dinitrophenyl)pyridinium chloride
5. This highly electrophilic compound 5 is then reacted with an (hetero)arylamine to give a new
N-(hetero)arylpyridinium salt 6 with elimination of 2,4-dinitroaniline [46–50]. This reaction will work
best if R is an electron-donor substituent.
Besides, several synthetic routes to N-alkylpyridinium compounds 7 are known, but the most
commonly used method is the Menschutkin reaction, an SN2 reaction of a pyridine derivative 3 with
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an alkyl halide or sulfonate (R’-X) (Scheme 2) [51,52]. This reaction is favored by electron-donor
substituents R on the pyridine ring. Moreover, pyridinium salts 6 and 7 are also synthesized from
the ring transformation reaction of pyrylium derivatives 8 with primary alkyl or (hetero)arylamines
(Scheme 2) [53,54].
Molecules 2019, 24, x FOR PEER REVIEW 3 of 32 
 
substituents R on the pyridine ring. Moreover, pyridinium salts 6 and 7 are also synthesized from the 
ring transformation reaction of pyrylium derivatives 8 with primary alkyl or (hetero)arylamines 
(Scheme 2) [53,54]. 
N
R
7
X
O2N
NO2
N
R
NO2
X– N
(hetero)aryl
R
X–
5
6
3
N
R'
X–
RR' X
O
R
X– 8
(hetero)aryl-NH2
(hetero)aryl-NH2H2O
R' NH2
H2O
2,4-dinitroaniline
4
NO2
 
Scheme 2. Synthetic routes to N-(hetero)arylpyridinium salts 6 and N-alkylpyridinium salts 7 starting 
from pyridines 3 or pyryliums 8 [46–54]. R’: alkyl, arylakyl; X: halides, sulfonates; R: electron-donor 
substituents, X: halides. 
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the [2+2+1+1] approach, involving an acid-mediated reaction between three equivalents of an 
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this reaction (Scheme 3); a major product, 1,2,3,5-tetrasubstituted pyridinium 12, which is formed via 
the auto-oxidation of the product 1,2,3,5-dihydropyridinium 11, and a minor product 1,3,5-
trisubstituted pyridinium derivative 13. However, the Chichibabine reaction requires harsh 
conditions, give low yields with numerous difficult to separate side products [57,58].  
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In previous articles [59–65] we have reported the synthesis of various perfluoroalkylated 
quinoline derivatives, by reacting perfluoroalkylated gem-iodoacyloxy derivatives 14 with 
substituted anilines 15. Later we observed that the presence of a ketone in the medium leads to the 
formation of arylpyridiniums instead of quinolines; what suggested an interesting alternative to 
published synthetic methods, and led us to design a new and efficient synthesis of substituted 2-
trifluoromethyl and 2-perfluoroalkyl-N-arylpyridinium derivatives 17–19 under mild reaction 
conditions and with very good yields. Mechanistic studies addressing possible intermolecular 
cycloaddition reactions are detailed, underlying possible chemical/biochemical mechanistic 
analogies in relation to the formation of pyridinium derivatives under biological conditions. 
Scheme 2. Synthetic routes to N-(hetero)arylpyridiniu salts 6 and N-alkylpyridinium salts 7 starting
from pyridines 3 or pyryliums 8 [46–54]. R’: alkyl, arylakyl; X: halides, sulfonates; R: electron-donor
substituents, X: halides.
Pyridinium compounds may also be synthesized by the Chichibabine reaction [55–58] based
on the [2+2+1+1] approach, involving an acid-mediated reaction between three equivalents of an
enolisable aldehyde 9 and one equivalent of amine 10. Typically, three products can be isolated from this
reaction (Scheme 3); a major product, 1,2,3,5-tetrasubstituted pyridinium 12, which is formed via the
auto-oxidation of the product 1,2,3,5-dihydropyridinium 11, and a minor product 1,3,5-trisubstituted
pyridinium derivative 13. Ho ever, the Chich babine re ction r quires harsh conditions, give low
yields with numerous difficult to separate side products [57,58].
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Scheme 3. Pyridinium synthetic routes through the Chichibabine reaction [55–58].
In previous articles [59–65] we have reported the synthesis of various perfluoroalkylated quinoline
derivatives, by reacting perfluoroalkylated gem-iodoacyloxy derivatives 14 with s bstituted anilines
15. Later we observed that the presence of a ketone in the medium leads to the formation of
arylpy idiniums instead of q inoli es; what s ggested an interesting alternative to published synthetic
methods, an led us to design new and efficie t synthesis o substitu ed 2-trifl orom thyl and
2-perfluoroalkyl-N-arylpyridinium derivatives 17–19 under mild reaction conditions and with very
good yields. Mechanistic studies addressing possible intermolecular cycloaddition reactions are
detailed, underlying possible chemical/biochemical mechanistic analogies in relation to the formation
of pyridinium derivatives under biological conditions.
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2. Results and Discussion
2.1. Synthesis
We report the reaction of 1-acetoxy-2-(perfluoroalkyl)-1-iodo-ethane 14–14” and various anilines
15a-n in the presence of acetone 16t (R1 = CH3, R2 = H), leading to the formation of 2-trifluoromethyl
and 2-perfluoroalkyl-6-methyl-N-arylpyridinium derivatives 17a–n’ in fair to excellent yields
(50–90%) (Scheme 4, Table 1). This reaction was then exemplified using two cyclic ketones,
namely cyclohexanone 16u and cycloheptanone 16v, both of which reacted smoothly to give
the corresponding 2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-5,6,7,8-tetrahydroquinoliniums
18a–n (R1-R2 = -(CH2)4-; Table 2) in good to excellent yields (75–90%) and 2-trifluoromethyl-/
2-perfluoroalkyl-N-(R-phenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridiniums 19a–m (R1–R2 =
-(CH2)5-; Table 3), respectively. All reactions proceeded with good to very good yields (70–90%).
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and 19F-NMR spectroscopy), allowed us to identify optimized conditions giving the best overall 
yields: namely one equivalent of gem-iodoacetate 14–14”, three equivalents of arylamine 15a–o and 
1.2 equivalents of ketone 16t–v in refluxing anhydrous dichloromethane. Reactions were typically 
completed within 4–12 h. A straightforward work-up allowed the isolation of pyridinium products 
17–19, through: (i) filtering off the excess anilinium salts that precipitated at the end of the reaction, 
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Scheme 4. Synthesis (optimize st ic i etries) of trifluoromethylated and perfluoroalkylated
6-methyl-N-arylpyridiniu s 17a–n’, -aryl-5,6,7,8-tetrahydroquinoliniums 18a–n and N-aryl-6,7,8,9-
tetrahydro-5H-cyclohepta[b]pyridiniums 19a– , exa ples in Tables 1–3 respectively (bottom right:
structures of compound series 17–19).
The numbering scheme for the investigated examples in compound series 17–19, is the following:
(i) the numbers 17–19 denote the compound series depending on the reacting ketone 16t–v; (ii) the
letter a–n denotes the aryl substituent inherited from the aniline substrate 15; (iii) the appended ’ or ”
denotes the perfluoroalkyl chain RF from perfluoroalkyl substrate 14: RF = C5F11 (14), CF3 (14’) or C3F7
(14”) respectively. For instance, 17a is obtained from 15a and 14, or 17n’ is obtained from 15n and 14’.
Thorough screening of reactants stoichiometries and reaction conditions (monitoring by TLC
and 19F-NMR spectroscopy), allowed us to identify optimized conditions giving the best overall
yields: namely one equivalent of gem-iodoacetate 14–14”, three equivalents of arylamine 15a–o and
1.2 equivalents of ketone 16t–v in refluxing anhydrous dichloromethane. Reactions were typically
completed within 4–12 h. A straightforward work-up allowed the isolation of pyridinium products
17–19, through: (i) filtering off the excess anilinium salts that precipitated at the end of the reaction,
then (ii) precipitating the product from the filtrate by addition of an appropriate solvent. Further
purification of 17–19 was carried out by final precipitation fro dichloro ethane-ether mixture, pure
2-perfluoroalkyl-N-arylpyridinium iodi es 17–19 being isolated as r s s li s.
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Table 1. Reaction conditions and conversions for the synthesis of substituted 2-trifluoromethyl-/
2-perfluoroalkyl-N-arylpyridinium compounds 17a–n’, using acetone 16t as reactant.
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6 14 C5F11 15d p-Me 4 17d 88
7 14’ CF3 15d p-Me 4 17d’ 88
8 14 C5F11 15e o-Et 6 17e 75
9 14 C5F11 15f m-Et 4 17f 80
10 14 C5F11 15g p-Et 4 17g 83
11 14’ CF3 15g p-Et 4 17g’ 85
12 14 C5F11 15h o-Cl 12 17h 65
13 14 C5F11 15i m-Cl 6 17i 75
14 14 C5F11 15j p-Cl 6 17j 83
15 14 C5F11 15k o-OMe 6 17k 75
16 14 C5F11 15l p-OMe 4 17l 78
17 14 C5F11 15m o-CO2H 12 17m 50
18 14’ CF3 15m o-CO2H 12 17m’ 52
19 14 C5F11 15n p-CO2H 12 17n 60
20 14’ CF3 15n p-CO2H 12 17n’ 62
a Determined by 19F-NMR analysis; NMR yield based on consumed 14 and formed 17.
Table 2. eaction conditions and conversions for the preparation of substituted 2-trifluoromethyl-/
2-perfluoroalkyl-N-(R-phenyl)-5,6,7,8-tetrahydroquinoliniums 18a–n, using cyclohexanone 16u
as reactant.
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Entry 14 15 Time Pyridiniums 18 Conv.
RF R (h) [%]a
1 14 C5F11 15a H 4 18a 85
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a Determined by 19F-NMR analysis; NMR yield based on consumed 14 and formed 18.
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Table 3. Reaction conditions and conversions for the preparation of 2-trifluoromethyl-/2-perfluoroalkyl-
N-(R-phenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridiniums 19a–m, using cyclo-heptanone 16v
as reactant.
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Figure 1. Structure of 6-methyl-2-perfluoropentyl-1-phenylpyridinium 17a and NMR resonance 
assignments.  
In its 1H-NMR spectrum, the singlet at δH 2.6 ppm (3H) is readily assigned to the methyl group 
which show a cross peak with the 13C resonance at δC 25 ppm in the 1H-13C HETCOR chart. Noticeably, 
upon shaking the samples dissolved in CDCl3 with one droplet of D2O, the methyl resonance of 17a 
readily disappears from the 1H spectrum, denoting a rapid H/D exchange which is explained by the 
acidic character of the protons on alkyl substituents of the pyridinium ring. 
N RF
I–
R19a-m
Entry 14 15 Time Pyridiniums 19 Conv.
RF R (h) [%]a
1 14 C5F11 15a H 4 19a 85
2 14 C5F11 15c m-Me 4 19c 83
3 14 C5F11 15d p-Me 4 19d 85
4 14 C5F11 15f m-Et 4 19f 88
5 14 C5F11 15g p-Et 4 19g 85
6 14 C5F11 15i m-Cl 4 19i 70
7 14 C5F11 15j p-Cl 4 19j 78
8 14 C5F11 15k o-OMe 6 19k 72
9 14 C5F11 15l p-OMe 4 19l 88
10 14 C5F11 15m o-CO2H 12 19m 70
a Determined by 19F-NMR analysis; NMR yield based on consumed 14 and formed 19.
2.2. Structure Determination of N-Arylpyridiniums 17–19
Structural assignments were accomplished without ambiguity by 1H-, 13C- and 19F-NMR as well
as 2D 1H-1H (COSY) and 1H-13C (HETCOR) NMR correlations. As an example, the NMR spectra of
6-methyl-2-perfluoropentyl-1-phenylpyridinium 17a (R = R2 = H, R1 = CH3, RF = C5F11) (Figure 1)
are typical and will be describ d in details: t 1H- and 13C-NMR spectra contain six and ten distinct
resonances, respectively (see 1D 1H and 13C-NMR in Supplementary M terials).
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Figure 1. Structure of 6-methyl-2-perfluoropentyl-1-phenylpyridinium 17a and NMR resonance
assignments.
In its 1H-NMR spectrum, the singlet at δH 2.6 ppm (3H) is readily assigned to the methyl group
which show a cross peak with the 13C resonance at δC 25 ppm in the 1H-13C HETCOR chart. Noticeably,
upon shaking the samples dissolved in CDCl3 with one droplet of D2O, the methyl resonance of 17a
readily disappears from the 1H spectrum, denoting a rapid H/D exchange which is explained by the
acidic character of the protons on alkyl substituents of the pyridinium ring.
1H resonances corresponding to the N-phenyl moiety, are divided into two groups: first a 3H
multiplet is observed at δH 7.5–7.6 ppm corresponding to the Hm and Hp on the meta- and para-
positions. Then, a slightly deshielded doublet resonance at δH 7.7 ppm corresponds to the two Ho
protons at ortho- positions. On the HETCOR chart, the meta- and para-hydrogens resonances show
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cross peaks with 13C resonances at δC 130.5 and 132.5 ppm, while the ortho- proton resonance also
show a clear cross peak with the 13C resonance at δC 126.7 ppm.
Besides, the most deshielded resonances at δH 8.3, 8.7 and 9.1 ppm, were assigned to the three
vicinal hydrogen atoms on the pyridinium nucleus (H3, H4 and H5) (Figure 1 and 1D 1H-NMR in
Supporting Information). This can be confirmed in the 1H-1H COSY chart where clear cross peaks
between those three resonances at δH 8.3, 8.7 and 9.1 ppm are observed. Moreover, those resonances
exhibit 3JH–H couplings constants of ca. 8–8.1 Hz characteristic of aromatic hydrogens.
Among them, the most deshielded resonance (δH 9.1 ppm) is a triplet signal, thus corresponding
to H4, due to vicinal couplings with two neighboring protons H3/H5 the resonances of which indeed
appear as two doublets at δH 8.3 and 8.7 ppm, which correlate with 13C resonances at δC 128.8 and
136.2 ppm respectively on the HETCOR chart. The final assignment between H3 and H5 was made
on basis of the presence of a 2.5 Hz triplet coupling on the 128.8-ppm 13C resonance explained as
a 3JCF coupling with fluorine nuclei on the vicinal CF2 group; thus both signals δH 8.3 ppm and δC
128.8 ppm belong to the H3/C3 position of the pyridinium ring, while the δH 8.7 ppm and δC 136.2 ppm
corresponds to H5/C5.
Three additional 13C resonances in the aromatic shift range, correspond to quaternary carbons
(invisible on DEPT spectra): the signal at δC 140.8 ppm appearing as a large triplet denotes a strong
coupling with fluorine nuclei of vicinal CF2 group (2JCF = 26.3 Hz), thus can nonambiguously be
attributed to carbon C2. Besides, on basis of a higher deshielding by the pyridinium ring, the two
other resonances at δC 163.8 and 137.8 ppm, were assigned to the carbon C6 and the ipso carbon of the
N-phenyl, respectively (Figure 1).
Interestingly, we also observed a large deshielding of the 19F-NMR resonance of the α-CF2
directly attached to the pyridinium ring, probably because of the high electron-withdrawing effect of
the adjacent positively charged nitrogen atom. This was similarly observed on the whole series of
perfluoroalkyl-substituted pyridiniums 17–19.
2.3. The m-Anisidine Case
A notable exception to the above synthesis results, was observed however with a meta-methoxy
substitution on substrate 15o (m-anisidine) where the only observed and isolated product was the
corresponding 2-perfluoroalkyl- or 2-trifluoromethyl-7-methoxyquinolines 20o (RF = C5F11) or 20o’
(RF = CF3) in 80–90% yields (Scheme 5 and Table 4); while the ketone 16 was recovered at the end of
the reaction (isolated and identified by NMR and mass spectrometry). In the absence of ketone 16
(namely upon reacting 14/14’ with three equivalents of 15o under identical conditions) the same result
was observed with similar yields of 20, what is actually consistent with our previous investigations on
such reactions [64].
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Scheme 5. Formation of 2-perfluoroalkyl-7-methoxyquinolines 20o–o’ in the case of aniline 15o (R = 
m-OMe), in the presence or absence of ketone 16; examples in Table 4.  
Schem 5. Formation f - erfluoroalkyl-7-methoxyquinolines 20o–o’ in the case of aniline 15o
(R = m-OMe), in the presence or absence of ketone 16; examples in Table 4.
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Table 4. Reaction conditions and conversions obtained for the formation of substituted
2-perfluoropentyl-/2-trifluoromethyl-7-methoxyquinolines (20o–o’), starting from m-anisidine 15o,
with or without ketone 16t–v.
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2.4. Re ctivity Investigation—Intermediate Isolation
Based on the observed reaction extents and required time for completion according to the
substituents (Tables 1–3), this series of investigated examples provided preliminary insights on the
reactivity of the system, where a primary factor of influence is likely the substitution of aniline 15.
For instance, the presence of an electron-withdrawing group on the aromatic ring of 15 resulted in
longer reaction times being required to reach completion, as observed e.g., with R = Cl or CO2H at
any o-, m-, p- position (Table 1, entries 12–14, 17–20; Table 2 entries 7, 9, 10; Table 3, entries 6–7, 10).
An ortho-substituted aniline 15 also resulted in an extended reaction time, whenever the o-substituent
was electron-donating or electron-withdrawing (R = o-Me, o-Et, o-OMe, o-Cl and o-CO2H; Table 1,
entries 4, 8, 12, 15, 17–18; Table 2, entries 3, 9; Table 3, entries 8, 10).
In order to better understand the mechanism of this reaction, its evolution was monitored by
19F-NMR spectroscopy, carried out on aliquots of the reaction medium diluted in CDCl3 or DMSO-d6,
then comparing the spectra of reaction mixtures with NMR data of compounds already investigated
and characterized in the course of our previous studies on gem-iodoacetoxy related systems [59–65].
We thus observed that the consumption of the starting 1-acetoxy-1-iodo-2-(perfluoroalkyl)-ethanes
14–14” was accompanied by the formation of an intermediate compound, the latter further disappeared
while the final 2-perfluoroalkyl-N-arylpyridinium products 17–19 were gradually formed. Comparison
with our previous NMR data provided fair assumption that such intermediate might be an
N,N’-diaryl-2-(perfluoroalkyl)-1,5-diazapenta-1,3-diene 21 (Scheme 6), a few examples of which
had previously been described by us [59,63,64].
In the absence of ketone 16 as reactant, and upon changing the other reactant stoichiometries
to those stated in our previous works [64] namely 1 equiv. 14–14” and 2 equiv. 15 (in DCM at rt:
21a–l,o–o’; or refluxing: 21m–n’), the main reaction product was the intermediate 21, the latter (21a–o’)
have been isolated in fair yields then characterized by NMR and mass spectrometry (Scheme 6).
All N,N’-diaryl-2-(perfluoroalkyl)-1,5-diazapenta-1,3-dienes 21a–o’ were actually isolated as mixtures
of E/Z-stereoisomers, as in our previous works [59,64,65].
2.5. Reactivity of Diazapentadienes 21
We then investigated the reactivity of diazapentadienes intermediates 21a–o’ in the presence of
ketones 16a–c, where we noticed that the presence of an additional amount of aniline 15 is necessary
to achieve pyridinium 17–19 formation. Thus, upon reacting isolated intermediates 21 with 1.2
equivalents of ketone 16 and one equivalent of arylamine 15 (the same substitution as used in the
formation of 21) in the presence of hydrogen iodide in refluxing dichloromethane, the consumption
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of 21 (monitored by TLC and 19F-NMR spectroscopy) was accompanied with the formation of the
corresponding 2-perfluoroalkyl-N-arylpyridiniums 17–19. Noteworthy from a reactivity/mechanistic
viewpoint, to our knowledge this is the first experimental evidence of the formation of arylpyridinium
compounds from an N,N’-diaryl-1,5-diazapenta-1,3-diene intermediate.
In the m-methoxy case (substrate 15o), while the derived diazapentadiene intermediate 21o/o’
was formed and isolated under identical conditions and with same yields as other examples a-n, the
subsequent reaction of isolated 21o/o’ in the presence of ketone 16 under the same conditions (one
equiv. 15o under acidic conditions), formed the 2-perfluoroalkyl-7-methoxyquinolines 20o/o’ as the
only products (Scheme 6, lower path), a result actually identical to the reaction of 21o/o’ with 15 in the
absence of ketone [64].
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through an acid catalyzed, addition-elimination mechanism to give a tautomeric N-phenyl-
imino/enamine intermediate 22 (Scheme 7). Then, the resulting intermediates 21 and 22 may react 
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inverse electron demand Diels-Alder (IEDDA) reaction involving the cycloaddition of the diene 21 
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Michaël addition of enamine 22 to diazapentadienes 21 then subsequent aminal-cyclisation. Both 
mechanisms could give a bis-anilinotetrahydropyridine (BATHP) intermediate 23. The latter then 
undergoes a double de-anilino-elimination, thus yielding the corresponding N-arylpyridinium 
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Scheme 6. Synthesis of N,N’-diaryl-2-(perfluoroalkyl)-1,5-diazapentadienes intermediates 21a–o’, and
further formation of 2-trifluoromethyl and 2-perfluoroalkyl-N-arylpyridinium derivatives 17–19 or
2-perfluoroalkyl-7-methoxyquinoline 20.
Based on required reactant stoichio etry, the echanis of the reactions may be rationalized
as follows (Scheme 7). In a first step, the gem-iodoacetoxy substrate 14/14” reacts with two
equivalents of arylamine 15 to form the corresponding diazapentadiene 21, according to our
previously reported investigations [64]. Meanwhile, another equivalent of arylamine 15 may condense
with ketone 16 through an acid catalyzed, addition-elimination mechanism to give a tautomeric
N-phenyl-imino/enamine intermediate 22 (Scheme 7). Then, the resulting intermediates 21 and 22 may
react together through two probably competing cyclization cascade mechanisms [66–70]: either: (i)
an inverse electron demand Diels-Alder (IEDDA) reaction involving the cycloaddition of the diene
21 and the electron-rich dienophile 22, or (ii) an aza-Robinson annulation-type reaction involving a
Michaël addition of enamine 22 to diazapentadienes 21 then subsequent aminal-cyclisation. Both
mechanisms could give a bis-anilinotetrahydropyridine (BATHP) intermediate 23. The latter then
undergoes a double de-anilino-elimination, thus yielding the corresponding N-arylpyridinium iodides
17–19 (Scheme 7).
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hypotheses of formation 2-trifluoromethyl and 2-perfluoroalkyl-N-arylpyridiniums 17–19.
BATHP: bis-anilino-tetrahydropyridine.
2.6. Formation of 2-Perfluoroalkyl-7-Methoxyanilines 20o–o’
The key step of this mechanism is the protonation of 21o and the formation of a conjugated
iminium intermediate (Scheme 8). Then Michael addition of m-methoxyaniline 15o gives a cationic
bis-anilino intermediate which undergo an intramolecular electrophilic aromatic cyclisation assisted
by the electron-donating methoxyl group with subsequent elimination of a m-methoxyaniline. Then a
prototropy induced by anilino-group followed by the loss of a proton and a second m-methoxyaniline
result in the generation of an aromatic ring and the formation of 2-perfluoroalkyl-7-methoxyanilines
20o–o’.
Conversely in the case of an m-methoxy substituted arylamine, the electron-donation ability of the
methoxy- substituent on the N,N’-(3-methoxyphenyl)-2-(perfluoroalkyl)-1,5-diazapentadienes 21o–o’,
may promote their direct intramolecular cyclization to 20 (Scheme 8) [59,64], the latter route also taking
advantage of an entropically favorable (unimolecular) cyclization over a bimolecular addition of 21o–o’
with 22o.
Indeed, the literature [71] states that electronic and steric effects of substituents have very
pronounced influence on both intermolecular Michaël 1,4-additions or Diels-Alder cycloadditions.
Many studies show that stereoelectronic requirements for certain intermolecular reaction and the
resulting increase in the potential energy for the corresponding transition states, could be so high that
intramolecular cyclisation could take place instead [71]. In both cases anyway (either cycloaddition or
cyclization), the subsequent elimination of two aniline molecules, may ensure irreversibility, again
because of entropic effects.
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3. Materials and Methods  
3.1. General Methods 
All reaction solvents were purchased from commercial suppliers and distilled before use. All 
synthetic reactions were performed in oven-dried glassware, and their progress was monitored by 
thin layer chromatography (TLC) using silica gel plates, and by 19F-NMR spectroscopy of aliquots. 
Chromatographic column purifications were performed on silica gel (40–63 μm). 1H, 13C, and 19F-
NMR spectra were recorded in either CDCl3 or DMSO-d6 solution on an Avance 300 (300 MHz) or an 
Avance 400 (400 MHz) spectrometer (Bruker, Billerica, MA, USA). Chemical shifts are reported in 
ppm, using the solvent signal chemical shift as a reference. Abbreviations used in the description of 
NMR spectra: s: singlet, d: doublet, t: triplet, q: quadruplet, bs: broad signal. Coupling constants (J) 
are given in Hertz. Mass spectra (either low- or high-resolution) were recorded on a SX102 mass 
spectrometer (JEOL, Tokyo, Japan) in FAB+ mode, using 3-nitrobenzyl alcohol matrix. Elemental 
analyses were carried out on a Flash 2000 elemental analyzer (Thermo Finnigan, Waltham, MA, 
USA). 
3.2. General Procedure for the Synthesis 2-Trifluoromethylated and 2-Perfluoroalkylated 6-Methyl-N-(R-
Phenyl)Pyridinium Iodides (17a–l), N-(R-Phenyl)-5,6,7,8-Tetrahydroquinolinium Iodides (18a–l) and N-(R-
Phenyl)-6,7,8,9-Tetrahydro-5H-Cyclohepta[B]Pyridinium Iodides (19a–l) (All examples except R = CO2H or 
R = M-Ome) 
To a stirred solution of 1-acetoxy-1-iodo-perfluoroalkylethane compounds 14 (1 equiv.) in 
anhydrous dichloromethane (10 mL DCM for 1g of 14), was added 3 equiv. of the corresponding 
substituted aniline 15 and 1.2 equiv. of ketone 16. The mixture was stirred under reflux for the desired 
time (4–12 h, Tables 1–3) until complete consumption of 14 (monitored by TLC eluent petroleum 
ether/ethyl acetate: 80/20 v/v and 19F-NMR spectroscopy of aliquots). When the reaction was 
completed, the mixture was allowed to cool to r.t. then the brown precipitate accumulated during the 
reaction was separated by vacuum filtration (it was subsequently identified as anilinium salts by 
NMR and MS). Then ethyl ether was added to the filtrate and the corresponding pyridinium iodides 
17a–l, 18a–l, and 19a–l precipitate instantly and were isolated by vacuum filtration as amorphous 
solids 
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3. aterials and ethods
3.1. General Methods
All reaction solvents were purchased from commercial suppliers and distilled before use.
All synthetic reactions were performed in oven-dried glassware, and their progress was monitored by
thin layer chromatography (TLC) using silica gel plates, and by 19F-NMR spectroscopy of aliquots.
Chromatographic column purifications were performed on silica gel (40–63 µm). 1H, 13C, and 19F-NMR
spectra were recorded in either CDCl3 or DMSO-d6 solution on an Avance 300 (300 MHz) or an Avance
400 (400 MHz) spectrometer (Bruker, Billerica, MA, USA). Chemical shifts are reported in ppm, using
the solvent signal chemical shift as a reference. Abbreviations used in the description of NMR spectra:
s: singlet, d: doublet, t: triplet, q: quadruplet, bs: broad signal. Coupling constants (J) are given in
Hertz. Mass spectra (either low- or high-resolution) were recorded on a SX102 mass spectrometer
(JEOL, Tokyo, Japan) in FAB+ mode, using 3-nitrobenzyl alcohol matrix. Elemental analyses were
carried out on a Flash 2000 elemental analyzer (Thermo Finnigan, Waltham, MA, USA).
3.2. General Procedure for the Synthesis 2-Trifluoromethylated and 2-Perfluoroalkylated
6-Methyl-N-(R-Phenyl)Pyridinium Iodides (17a–l), N-(R-Phenyl)-5,6,7,8-Tetrahydroquinolinium Iodides
(18a–l) and N-(R-Phenyl)-6,7,8,9-Tetrahydro-5H-Cyclohepta[B]Pyridinium Iodides (19a–l) (All examples
exc pt R = CO2H or R = M-Ome)
To a stirred solution of 1-acetoxy-1-iodo-perfluoroalkylethane compounds 14 (1 equiv.) in
anhydrous dichloromethane (10 mL DCM for 1g of 14), was added 3 equiv. of the corresponding
substituted aniline 15 and 1.2 equiv. of ketone 16. The mixture was stirred under reflux for the desired
time (4–12 h, Tables 1–3) until co plete consumption of 14 (monitored by TLC eluent petr leum
ether/e hyl acetate: 80/20 v/v and 19F-NMR spectroscopy of aliquots). Wh n the r action was completed,
the mixture was llowed to cool to r.t. then the brown precipitate accumulated during th reaction was
s pa ated by vacuum filtration (it was subsequently identified as anilinium salts by NMR and MS).
Then ethyl e r was added to the filtrate and the corresponding pyridinium iodides 17a–l, 18a–l, and
19a–l precipitat instantly and were iso ated by vacuum filtration as amorphous solids.
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2-Perfluoropentyl-6-methyl-N-phenylpyridinium iodide (17a). Aniline 15a (5.24 g, 5.63 × 10−2 mole) and
acetone (16t, 1.65 mL, 1.3 g, 2.25 × 10−2 mole) were added to a solution of 14 (RF = C5F11, 10 g, 1.87 ×
10−2 mole) in dry dichloromethane (100 mL). The mixture was stirred for 2 h at reflux to afford 9.55 g of
the title product 17a, total yield 90%. 1H-NMR (400.13 MHz, CDCl3) δ 2.6 (s, 3H, CH3), 7.5–7.6 (m, 3H,
Ph-H), 7.7 (d, J = 7.1 Hz, 2H, Ph-H), 8.3 (d, J = 8 Hz, 1H, Py-H), 8.7 (d, J = 8 Hz, 1H, Py-H), 9.1 (t, J = 8.1
Hz, 1H, Py-H); 1H-NMR (400.13 MHz, CDCl3+D2O) δ 7.5–7.6 (m, 3H, Ph-H), 7.7 (d, J = 7.2 Hz, 2H,
Ph-H), 8.3 (d, J = 8 Hz, 1H, Py-H), 8.7 (d, J = 8.1 Hz, 1H, Py-H), 9.1 (t, J = 8.1 Hz, 1H, Py-H); 13C-NMR
(100.6 MHz, CDCl3) δ 25 (s, CH3), 126.7, 128.8 (t, 3JCF = 2.5 Hz), 130.4, 132.5, 136.2, 137.8, 140.8 (t, 2JCF =
26.3 Hz), 148, 163.8; 19F-NMR (235.3 MHz, CDCl3) δ −126.5 (m 2F, CF2-CF2-CF2-CF2-CF3), −123 (m
2F, CF2-CF2-CF2-CF2-CF3), −118 (m 2F, CF2-CF2-CF2-CF2-CF3), −102.5 (m 2F, CF2-CF2-CF2-CF2-CF3),
−81.5 (m 3F, CF2-CF2-CF2-CF2-CF3). MS (m/z): 438 ([M − I]+, 100). HRMS calcd. for C17H11F11N+
438.0716, found 438.0720. Anal. Calcd. for C17H11F11NI: C, 36.13; H, 1.96; N, 2.48. Found: C, 36.15; H,
1.95; N, 2.46.
2-Trifluoromethyl-6-methyl-N-phenylpyridinium iodide (17a’). Aniline 15a (8.4 g, 9 × 10−2 mol) and acetone
(16t, 2.7 mL, 2 g, 3.61 × 10−2 mol) were added to a solution of 14’ (RF = CF3, 10 g, 3 × 10−2 mol) in dry
dichloromethane (100 mL). The mixture was stirred for 2 h at reflux to give 9.9 g of the title product 17a’,
total yield 90%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 2.6 (s, 3H, CH3), 7.5–7.6 (m, 3H), 7.8 (d,
J = 9 Hz, 2H), 8.5 (dd, J = 9 and 3 Hz, 1H), 8.6 (dd, J = 9 and 3 Hz, 1H), 9 (t, J = 9 Hz, 1H); 13C-NMR
(75.46 MHz, CDCl3) δ 24.1 (s, CH3), 118.6 (q, CF3, 1JCF = 276.9 Hz), 125.6 (q, 3JCF = 5.2 Hz), 125.7, 130.1,
132.3, 135.1, 136.7, 140.9 (q, C-CF3, 2JCF = 35.4 Hz), 148, 162.5; 19F-NMR (282.4 MHz, CDCl3) δ −59.8 (s
3F, CF3). MS (m/z): 238 ([M − I]+, 100). HRMS calcd. for C13H11F3N+: 238.0844, found 238.0848. Anal.
Calcd. for C13H11F3NI: C, 42.76; H, 3.04; N, 3.84. Found: C, 42.78; H, 3.05; N, 3.82.
2-Perfluoropropyl-6-methyl-N-phenylpyridinium iodide (17a”). Aniline 15a (6.45 g, 6.94 × 10−2 mol) and
acetone (16t, 1.6 mL, 2 g, 2.77 × 10−2 mol) were added to a solution of 14” (RF = C3F7, 10 g, 2.31 ×
10−2 mol) in dry dichloromethane (100 mL). The mixture was stirred for 2 h at reflux, affording 9.69 g
of the title product 17a”, total yield 91%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 2.6 (s, 3H,
CH3), 7.5–7.6 (m, 3H), 7.7 (d, J = 7 Hz, 2H), 8.3 (d, J = 8.1 Hz, 1H), 8.8 (d, J = 8 Hz, 1H), 9 (t, J = 8 Hz,
1H); 13C-NMR (100.6 MHz, CDCl3) δ 25.1 (s, CH3), 126.5, 128.7 (t, 3JCF = 2.5 Hz), 130.4, 132.2, 136.1,
137.7, 140.9 (t, 2JCF = 26.5 Hz), 148, 163.7; 19F-NMR (235.3 MHz, CDCl3) δ −127 (m 2F, CF2), −102 (m 2F,
CF2), −80.5 (m 3F, CF3). MS (m/z): 338 ([M − I]+, 100). HRMS calcd. for C15H11F7N+: 338.0780, found
338.0782. Anal. Calcd. for C15H11F7NI: C, 38.73; H, 2.38; N, 3.01. Found: C, 38.75; H, 2.39; N, 3.04.
2-Perfluoropentyl-6-methyl-N-(2-methylphenyl)pyridinium iodide (17b). 2-Methylaniline (15b, 6 g, 5.63 ×
10−2 mol) and acetone (16t, 1.66 mL, 1.3 g, 2.25 × 10−2 mol) were added to a solution of 14 (RF = C5F11,
10 g, 1.87 × 10−2 mol) in dry dichloromethane (100 mL). The mixture was stirred for 4 h at reflux, to
give 8.7 g of the title product 17b, total yield 80%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 2.5
(s, 3H, CH3), 2.6 (s, 3H, CH3), 7.4–7.6 (m, 4H), 7.9 (t, J = 7.2 Hz, 1H), 8.2 (d, J = 8.1 Hz, 1H), 8.9 (d,
J = 8.2 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 20.1 (s, CH3), 25 (s, CH3), 127, 128.5 (t, 3JCF = 2 Hz),
130.5, 131.9, 136.1, 138, 141.1 (t, 2JCF = 26 Hz), 148, 163.5; 19F-NMR (282.4 MHz, CDCl3) δ −125.7 (m
2F, CF2), −122.1 (m 2F, CF2), −118.2 (AB system, 2JFF = 338.8 Hz, 1F, CF2-CF2-CF2), −116 (AB system,
2JFF = 338.8 Hz, 1F, CF2-CF2-CF2), −108.5 (AB system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2), −98 (AB
system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2), −80.6 (m 3F, CF3). MS (m/z): 452 ([M − I]+, 100). HRMS
calcd. for C18H13F11N+: 452.0872, found 452.0877. Anal. Calcd. for C18H13F11NI: C, 37.33; H, 2.26; N,
2.42. Found: C, 37.35; H, 2.30; N, 2.40.
2-Perfluoropentyl-6-methyl-N-(3-methylphenyl)pyridinium iodide (17c). 3-Methylaniline (15c, 6.34 g, 5.92 ×
10−2 mol) and acetone (16t, 1.75 mL, 1.37 g, 2.36 × 10−2 mol) were added to a solution of 14 (RF = C5F11,
0.5 g, 1.97 × 10−2 mol) in dry dichloromethane (105 mL). The mixture was stirred for 4 h at reflux to
give 9.7 g of the title product 17c, total yield 85%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ 2.6
(s, 3H, CH3), 2.7 (s, 3H, CH3), 7.4–7.6 (m, 4H), 8.3 (d, J = 7.2 Hz, 1H), 8.8 (d, J = 8.1 Hz, 1H), 9.2 (t,
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J = 8.1 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 22 (s, CH3), 26 (s, CH3), 121, 123, 128 (t, 3JCF = 2 Hz),
130.5, 132, 136.1, 137, 139 (t, 2JCF = 25 Hz), 145, 148, 161; 19F-NMR (282.4 MHz, CDCl3) δ −126 (s 2F,
CF2), −122.4 (s 2F, CF2), −117.2 (s 2F, CF2), −103.5 (AB system, 2JFF = 310.6 Hz, 1F, CF2-CF2), −101.1
(AB system, 2JFF = 310.6 Hz, 1F, CF2-CF2), −80.7 (m 3F, CF3). MS (m/z): 452 ([M − I]+, 95). HRMS calcd.
for C18H13F11N+: 452.0872, found 452.0875. Anal. Calcd. for C18H13F11NI: C, 37.33; H, 2.26; N, 2.42.
Found: C, 37.36; H, 2.28; N, 2.40.
2-Perfluoropentyl-6-methyl-N-(4-methylphenyl)pyridinium iodide (17d). 4-Methylaniline (15d, 5.74 g, 5.35
× 10−2 mol) and acetone (16t, 1.58 mL, 1.24 g, 2.14 × 10−2 mol) were added to a solution of 14 (RF =
C5F11, 9.5 g, 1.78 × 10−2 mol) in dry dichloromethane (95 mL). The mixture was stirred for 4 h at reflux
to afford 8.79 g of the title product 17d, total yield 85%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ
2.65 (s, 3H, CH3), 2.7 (s, 3H, CH3), 7.4 (d, J = 8 Hz, 2H), 7.7 (d, J = 8 Hz, 2H), 8.3 (d, J = 8.2 Hz, 1H),
8.8 (d, J = 8.3 Hz, 1H), 9 (t, J = 8.2 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 25 (s, CH3), 26.1 (s, CH3),
122.7, 126.5, 127.7 (t, 3JCF = 1.5 Hz), 129.9, 130, 135.1, 137.8 (t, 2JCF = 27.2 Hz), 142.5, 146.6, 150.2, 167.5;
19F-NMR (282.4 MHz, CDCl3) δ −126 (s 2F, CF2), −122.4 (s 2F, CF2), −117.2 (s 2F, CF2), −101.6 (s, 2F,
CF2-CF2), −80.7 (m 3F, CF3). MS (m/z): 452 ([M − I]+, 100). HRMS calcd. for C18H13F11N+: 452.0872,
found 452.0878. Anal. Calcd. for C18H13F11NI: C, 37.33; H, 2.26; N, 2.42. Found: C, 37.37; H, 2.26; N,
2.39.
2-Trifluoromethyl-6-methyl-N-(4-methylphenyl)pyridinium iodide (17d’). 4-Methylaniline (15d, 8.81 g, 8.22
× 10−2 mol) and acetone (16t, 2.43 mL, 1.9 g, 3.28 × 10−2 mol) were added to a solution of 14’ (RF =
CF3, 9.1 g, 2.74 × 10−2 mol) in dry dichloromethane (91 mL). The mixture was stirred for 4 h at reflux
to yield 9.14 g of the title product 17d’, total yield 88%. Spectral data: 1H-NMR (400.13 MHz, CDCl3) δ
2.6 (s, 3H, CH3), 2.7 (s, 3H, CH3), 7.4 (d, J = 8.1 Hz, 2H), 7.7 (d, J = 8 Hz, 2H), 8.3 (d, J = 8 Hz, 1H), 8.7 (d,
J = 8.1 Hz, 1H), 9.2 (t, J = 8.1 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 24.2 (s, CH3), 25 (s, CH3), 118.4
(q, CF3, 1JCF = 276.8 Hz), 124.8 (q, 3JCF = 5 Hz), 122.5, 125.6, 130, 132.3, 140.9 (q, C-CF3, 2JCF = 36 Hz),
147.2, 150, 162.5; 19F-NMR (282.4 MHz, CDCl3) δ −59.9 (s 3F, CF3). MS (m/z): 252 ([M − I]+, 95). HRMS
calcd. for C14H13F3N+: 252.100, found 252.1010. Anal. Calcd. for C14H13F3NI: C, 44.35; H, 3.46; N,
3.69. Found: C, 44.38; H, 3.47; N, 3.70.
2-Perfluoropentyl-6-methyl-N-(2-ethylphenyl)pyridinium iodide (17e). 2-Ethylaniline (15e, 7 g, 5.8 × 10−2
mol) and acetone (16t, 1.7 mL, 1.34 g, 2.32 × 10−2 mol) were added to a solution of 14 (RF = C5F11,
10.3 g, 1.93 × 10−2 mol) in dry dichloromethane (103 mL). The mixture was stirred for 6 h at reflux
to produce 8 g of the title product 17e, total yield 70%. Spectral data: 1H-NMR (400.13 MHz, CDCl3)
δ 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.6 (q, J = 8 Hz, 2H, CH2-CH3), 2.8 (s, 3H, CH3), 7.4–7.6 (m, 3H),
8 (s, 1H), 8.2 (d, J = 8 Hz, 1H), 8.9 (d, J = 8.1 Hz, 1H); 9.2 (t, J = 8.1 Hz, 1H); 13C-NMR (100.6 MHz,
CDCl3) δ 13.2 (s, CH2-CH3), 24.3 (s, CH2-CH3), 27.1 (s, CH3), 124.2, 125.9, 127.8 (t, 3JCF = 2.1 Hz),
129.6, 131, 136.1, 137.5 (t, 2JCF = 25 Hz), 146.5, 150.1, 167.7; 19F-NMR (282.4 MHz, CDCl3) δ −126 (m
2F, CF2), −122.9 (AB system, 2JFF = 289.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.8 (AB system, 2JFF =
289.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −118.7 (AB system, 2JFF = 300.9 Hz, 1F, CF2-CF2-CF2-CF2-CF3),
−115.9 (AB system, 2JFF = 300.9 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −108.5 (AB system, 2JFF = 289.6 Hz, 1F,
CF2-CF2-CF2-CF2-CF3), −98.8 (AB system, 2JFF = 289.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.7 (m 3F,
CF3). MS (m/z): 466 ([M − I]+, 95). HRMS calcd. for C19H15F11N+: 466.1029, found 466.1033. Anal.
Calcd. for C19H15F11NI: C, 38.47; H, 2.55; N, 2.36. Found: C, 38.48; H, 2.56; N, 2.40.
2-Perfluoropentyl-6-methyl-N-(3-ethylphenyl)pyridinium iodide (17f). 3-Ethylaniline (15f, 7.17 g, 5.92 ×
10−2 mol) and acetone (16t, 1.75 mL, 1.37 g, 2.36 × 10−2 mol) were added to a solution of 14 (RF = C5F11,
10.5 g, 1.97 × 10−2 mol) in dry dichloromethane (105 mL). The mixture was stirred for 4 h at reflux to
obtain. 9.36 g of the title product 17f, total yield 80%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ
1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.7 (s, 3H, CH3), 2.8 (q, J = 8 Hz, 2H, CH2-CH3), 7.4–7.7 (m, 4H), 8.4 (d,
J = 6.7 Hz, 1H), 8.9 (d, J = 7.1 Hz, 1H), 9.2 (t, J = 7.9 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 13 (s,
CH2-CH3), 23 (s, CH2-CH3), 27 (s, CH3), 121.5, 123.5, 127 (t), 128, 130, 134, 135, 139 (t, 2JCF = 25 Hz),
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145, 146, 162; 19F-NMR (282.4 MHz, CDCl3) δ −126 (s 2F, CF2), −122.4 (s 2F, CF2), −117.2 (s 2F, CF2),
−102.5 (AB system, 2JFF = 315.5 Hz, 1F, CF2-CF2), −101.5 (AB system, 2JFF = 315.5 Hz, 1F, CF2-CF2),
−80.7 (m 3F, CF3). MS (m/z): 466 ([M − I]+, 100). HRMS calcd. for C19H15F11N+: 466.1029, found
466.1035. Anal. Calcd. for C19H15F11NI: C, 38.47; H, 2.55; N, 2.36. Found: C, 38.49; H, 2.56; N, 2.33.
2-Perfluoropentyl-6-methyl-N-(4-ethylphenyl)pyridinium iodide (17g). 6.9 g of 4-ethylaniline 15g (5.69 ×
10−2 mol) and 1.68 mL or 1.32 g (2.27 × 10−2 mol) of acetone 16t were added to a solution of 10.1 g
(1.89 × 10−2 mol) of 14 (RF = C5F11) in 101 mL of dry dichloromethane. The mixture was stirred for
4 h at reflux. 9.34 g of the title product 17g were obtained, total yield 83%. Spectral data: 1H-NMR
(300.13 MHz, CDCl3) δ 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.7 (s, 3H, CH3), 2.8 (q, J = 8 Hz, 2H, CH2-CH3),
7.1 (d, J = 8.4 Hz, 2H), 7.7 (d, J = 8.3 Hz, 2H), 8.4 (d, J = 7.5 Hz, 1H), 8.8 (d, J = 7.8 Hz, 1H), 9.1 (t, J = 7.8
Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 13 (s, CH2-CH3), 24 (s, CH2-CH3), 26.8 (s, CH3), 113.5, 126.5,
127.5 (t, 3JCF = 2 Hz), 129.5, 130, 135, 139 (t, 2JCF = 25 Hz), 147, 159, 162; 19F-NMR (282.4 MHz, CDCl3) δ
−126.9 (s 2F, CF2), −123.3 (s 2F, CF2), −117.3 (s 2F, CF2), −101.8 (s, 2F, CF2-CF2), −80.7 (m 3F, CF3). MS
(m/z): 466 ([M − I]+, 100). HRMS calcd. for C19H15F11N+: 466.1029, found 466.1030. Anal. Calcd. for
C19H15F11NI: C, 38.47; H, 2.55; N, 2.36. Found: C, 38.48; H, 2.56; N, 2.35.
2-Trifluoromethyl-6-methyl-N-(4-ethylphenyl)pyridinium iodide (17g’). 9.85 g of 4-ethylaniline 15g (8.13
× 10−2 mol) and 2.4 mL or 1.88 g (3.25 × 10−2 mol) of acetone 16t were added to a solution of 9 g
(2.71 × 10−2 mol) of 14’ (RF = CF3) in 90 mL of dry dichloromethane. The mixture was stirred for
4 h at reflux. 9 g of the title product 17g’ were obtained, total yield 85%. Spectral data: 1H-NMR
(400.13 MHz, CDCl3) δ 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.7 (s, 3H, CH3), 2.8 (q, J = 8 Hz, 2H, CH2-CH3),
7.1 (d, J = 8 Hz, 2H), 7.7 (d, J = 8 Hz, 2H), 8.2 (d, J = 8 Hz, 1H), 8.7 (d, J = 8 Hz, 1H), 9 (t, J = 8.1 Hz,
1H); 13C-NMR (75.46 MHz, CDCl3) δ 13.2 (s, CH2-CH3), 23.9 (s, CH2-CH3), 27 (s, CH3), 118.1 (q, CF3,
1JCF = 277.6 Hz), 125 (q, 3JCF = 4.8 Hz), 122.4, 125.7, 130.2, 132, 147.2 (q, C-CF3, 2JCF = 35.5 Hz), 149.9,
162; 19F-NMR (282.4 MHz, CDCl3) δ −58.9 (s 3F, CF3). MS (m/z): 266 ([M − I]+, 100). HRMS calcd. for
C15H15F3N+: 266.1157, found 266.1160. Anal. Calcd. for C15H15F3NI: C, 45.82; H, 3.85; N, 3.56. Found:
C, 45.85; H, 3.86; N, 3.52.
2-Perfluoropentyl-6-methyl-N-(2-chlorophenyl)pyridinium iodide (17h). 7.4 g of 2-chloroaniline 15h (5.8 ×
10−2 mol) and 1.7 mL or 1.34 g (2.32 × 10−2 mol) of acetone 16t were added to a solution of 10.3 g (1.93 ×
10−2 mol) of 14 (RF = C5F11) in 103 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux.
6.96 g of the title product 17h were obtained, total yield 60%. Spectral data: 1H-NMR (400.13 MHz,
CDCl3) δ 2.8 (s, 3H, CH3), 7.7–7.9 (m, 3H), 8.4 (m, 1H), 8.5 (d, J = 8 Hz, 1H), 8.9 (d, J = 8.1 Hz, 1H); 9.4
(t, J = 8 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 24.2 (s, CH3), 128.5, 129.1, 130.1, 130.8, 133.8, 135,
136.2, 140.5 (t, 2JCF = 24.1 Hz), 148.8, 163.8; 19F-NMR (282.4 MHz, CDCl3) δ −126.5 (AB system, 2JFF
= 289 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.7 (AB system, 2JFF = 289 Hz, 1F, CF2-CF2-CF2-CF2-CF3),
−122.9 (AB system, 2JFF = 289.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.6 (AB system, 2JFF = 289.6 Hz,
1F, CF2-CF2-CF2-CF2-CF3), −118.7 (AB system, 2JFF = 299.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −115.9
(AB system, 2JFF = 299.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −108.2 (AB system, 2JFF = 288.6 Hz, 1F,
CF2-CF2-CF2-CF2-CF3), −98.8 (AB system, 2JFF = 288.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.7 (m 3F,
CF3). MS (m/z): 472 ([M − I]+, 90). HRMS calcd. for C17H10ClF11N+: 472.0326, found 472.0329. Anal.
Calcd. for C17H10ClF11NI: C, 34.05; H, 1.68; N, 2.34. Found: C, 34.08; H, 1.67; N, 2.33.
2-Perfluoropentyl-6-methyl-N-(3-chlorophenyl)pyridinium iodide (17i). 7.55 g of 3-chloroaniline 15i (5.92 ×
10−2 mol) and 1.75 mL or 1.37 g (2.36 × 10−2 mol) of acetone 16t were added to a solution of 10.5 g
(1.97 × 10−2 mol) of 14 (RF = C5F11) in 105 mL of dry dichloromethane. The mixture was stirred for
6 h at reflux. 8.28 g of the title product 17i were obtained, total yield 70%. Spectral data: 1H-NMR
(400.13 MHz, CDCl3) δ 2.7 (s, 3H, CH3), 7.3 (s, 1H), 7.4–7.6 (m, 2H), 7.7 (m, 1H), 8.3 (d, J = 8 Hz, 1H),
8.5 (d, J = 8 Hz, 1H), 8.8 (t, J = 8 Hz, 1H); 13C-NMR (100.6 MHz, CDCl3) δ 27.3 (s, CH3), 127.9, 129.6,
131.4, 134.1, 135.5, 138.5 (t, 2JCF = 25 Hz), 141.1, 150.6, 166.4; 19F-NMR (282.4 MHz, CDCl3) δ −121.5 (s
2F, CF2), −117.5 (s 2F, CF2), −112.7 (s 2F, CF2), −97.4 (AB system, 2JFF = 105.3 Hz, 1F, CF2-CF2), −97.1
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(AB system, 2JFF = 105.3 Hz, 1F, CF2-CF2), −75.9 (m 3F, CF3). MS (m/z): 472 ([M − I]+, 90). HRMS calcd.
for C17H10ClF11N+: 472.0326, found 472.0330. Anal. Calcd. for C17H10ClF11NI: C, 34.05; H, 1.68; N,
2.34. Found: C, 34.11; H, 1.65; N, 2.36.
2-Perfluoropentyl-6-methyl-N-(4-chlorophenyl)pyridinium iodide (17j). 7.19 g of 4-chloroaniline 15j (5.63
× 10−2 mol) and 1.66 mL or 1.3 g (2.25 × 10−2 mol) of acetone 16t were added to a solution of 10 g
(1.87 × 10−2 mol) of 14 (RF = C5F11) in 100 mL of dry dichloromethane. The mixture was stirred for
6 h at reflux. 9.58 g of the title product 17j were obtained, total yield 85%. Spectral data: 1H-NMR
(300.13 MHz, CDCl3) δ 2.5 (s, 3H, CH3), 7.9 (d, J = 8 Hz, 2H), 8.2 (d, J = 8.1 Hz, 2H), 8.6 (d, J = 8 Hz,
1H), 8.8 (d, J = 7.9 Hz, 1H), 9 (t, J = 7.9 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 26 (s, CH3), 113.2,
126, 127.4 (t, 3JCF = 2.2 Hz), 130.2, 136, 139.2 (t, 2JCF = 24.8 Hz), 147.2, 158, 162.3; 19F-NMR (282.4 MHz,
CDCl3) δ −125.8 (s 2F, CF2), −122.3 (s 2F, CF2), −117.7 (s 2F, CF2), −101.8 (s, 2F, CF2-CF2), −80.2 (m 3F,
CF3); MS (m/z): 472 ([M − I]+, 90). HRMS calcd. for C17H10ClF11N+: 472.0326, found 472.0324. Anal.
Calcd. for C17H10ClF11NI: C, 34.05; H, 1.68; N, 2.34. Found: C, 34.10; H, 1.68; N, 2.35.
2-Perfluoropentyl-6-methyl-N-(2-methoxyphenyl)pyridinium iodide (17k). 6.8 g of 2-methoxyaniline 15k
(5.52 × 10−2 mol) and 1.63 mL or 1.28 g (2.21 × 10−2 mol) of acetone 16t were added to a solution of 9.8
g (1.84 × 10−2 mol) of 14 (RF = C5F11) in 98 mL of dry dichloromethane. The mixture was stirred for
6 h at reflux. 7.67 g of the title product 17k were obtained, total yield 70%. Spectral data: 1H-NMR
(300.13 MHz, CDCl3) δ 2.8 (s, 3H, CH3), 3.7 (s, 3H, OCH3), 7.1 (d, J = 8.3 Hz, 1H), 7.2 (t, J = 7.6 Hz,
1H), 7.7 (t, J = 8.8 Hz, 1H), 8 (m, 1H), 8.3 (d, J = 8.1 Hz, 1H), 8.8 (d, J = 8.2 Hz, 1H), 9 (d, J = 8.2
Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ 22.2 (s, CH3), 54 (s, OCH3), 113.1, 128.5, 129.1, 130.8, 133.7,
136.2, 139.9 (t, 2JCF = 25 Hz), 147, 160, 162.2; 19F-NMR (282.4 MHz, CDCl3) δ −126.5 (AB system, 2JFF
= 295 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.5 (AB system, 2JFF = 295 Hz, 1F, CF2-CF2-CF2-CF2-CF3),
−122.9 (AB system, 2JFF = 289 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.5 (AB system, 2JFF = 289 Hz, 1F,
CF2-CF2-CF2-CF2-CF3), −119 (AB system, 2JFF = 288 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −116.5 (AB system,
2JFF = 288 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −107 (AB system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3),
−99.5 (AB system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.69 (m 3F, CF3). MS (m/z): 468 ([M −
I]+, 100). HRMS calcd. for C18H13F11NO+: 468.0821, found 468.0827. Anal. Calcd. for C18H13F11INO:
C, 36.32; H, 2.20; N, 2.35. Found: C, 36.35; H, 2.21; N, 2.34.
2-Perfluoropentyl-6-methyl-N-(4-methoxyphenyl)pyridinium iodide (17l). 6.94 g of 4-methoxyaniline 15l
(5.63 × 10−2 mol) and 1.66 mL or 1.3 g (2.25 × 10−2 mol) of acetone 16t were added to a solution of 10 g
(1.87 × 10−2 mol) of 14 (RF = C5F11) in 100 mL of dry dichloromethane. The mixture was stirred for
4 h at reflux. 9.62 g of the title product 17l were obtained, total yield 86%. Spectral data: 1H-NMR
(300.13 MHz, CDCl3) δ 2.7 (s, 3H, CH3), 3.9 (s, 3H, OCH3), 7.2 (d, J = 8.5 Hz, 2H), 7.7 (d, J = 8.4 Hz, 2H),
8.4 (d, J = 7.5 Hz, 1H), 8.8 (d, J = 7.8 Hz, 1H), 9.1 (t, J = 7.8 Hz, 1H); 13C-NMR (75.46 MHz, CDCl3) δ
22.3 (s, CH3), 54.2 (s, OCH3), 113, 128.7 (t, 3JCF = 2 Hz), 129.4, 130.5, 133, 136.1, 140 (t, 2JCF = 25 Hz),
147, 160.2, 162.5; 19F-NMR (282.4 MHz, CDCl3) δ −126.1 (s 2F, CF2), −122.3 (s 2F, CF2), −117.1 (s 2F,
CF2), −101.8 (s, 2F, CF2-CF2), −80.7 (m 3F, CF3). MS (m/z): 468 ([M − I]+, 100). HRMS calcd. for
C18H13F11NO+: 468.0821, found 468.0830. Anal. Calcd. for C18H13F11INO: C, 36.32; H, 2.20; N, 2.35.
Found: C, 36.39; H, 2.21; N, 2.38.
2-Perfluoropentyl-N-(phenyl)-5,6,7,8-tetrahydroquinolinium iodide (18a). 5.24 g of aniline 15a (5.63 × 10−2
mole) and 2.21 g (2.25 × 10−2 mole) of cyclohexanone 16u were added to a solution of 10 g (1.87 × 10−2
mole) of 14 (RF = C5F11) in 50 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux.
10 g of the title product 18a were obtained, total yield 88%. Spectral data: 1H-NMR (300.13 MHz,
CDCl3) δ 2 (m, 4H), 2.7 (m, 2H), 3.3 (m, 2H), 7.5–7.6 (m, 3H), 7.7 (d, J = 7.1 Hz, 2H), 8.2 (d, J = 8.1 Hz,
1H), 8.7 (d, J = 8.2 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 19.5, 21, 29.5, 31.2, 115, 125.1, 127, 128.1,
129.2, 139 (t, 2JCF = 27 Hz), 146, 148.1, 163.1; 19F-NMR (235.3 MHz, CDCl3) δ −126.2 (m 2F, CF2), −122.4
(m 2F, CF2), −117.3 (m 2F, CF2), −101.8 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 478 ([M − I]+, 95).
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HRMS calcd. for C20H15F11N+ 478.1029, found 478.1033. Anal. Calcd. for C20H15F11NI: C, 39.69; H,
2.50; N, 2.31. Found: C, 39.72; H, 2.51; N, 2.29.
2-Trifluoromethyl-N-(phenyl)-5,6,7,8-tetrahydroquinolinium iodide (18a’). 7.14 g of aniline 15a (7.68 × 10−2
mol) and 3 g (3.07 × 10−2 mol) of cyclohexanone 16u were added to a solution of 8.5 g (2.56 × 10−2 mol)
of 14’ (RF = CF3) in 85 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 9.23 g of
the title product 18a’ were obtained, total yield 89%. 1H-NMR (300.13 MHz, CDCl3) δ 1.9 (m, 4H, CH2,
cyclohexyl group), 2.6 (m, 2H, CH2, cyclohexyl group), 3.3 (m, 2H, CH2, cyclohexyl group), 7.5–7.6
(m, 3H, Ph-H), 7.8 (d, J = 7.5 Hz, 2H, Ph-H), 8.2 (d, J = 8 Hz, 1H, Py-H), 8.8 (d, J = 8.1 Hz, 1H, Py-H);
13C-NMR (75.46 MHz, CDCl3) δ 19.8, 21, 29.6, 32.2, 115, 118.6 (q, CF3, 1JCF = 282.5 Hz), 125.2, 127.1,
128.8, 129.2, 139.5, 146.4, 148.5 (q, C-CF3, 2JCF = 34.5 Hz), 163; 19F-NMR (282.4 MHz, DMSO-d6) δ −59.8
(s 3F, CF3). MS (m/z): 278 ([M − I]+, 95). HRMS calcd. for C16H15F3N+: 278.1157, found 278.1160. Anal.
Calcd. for C16H15F3NI: C, 47.43; H, 3.73; N, 3.46. Found: C, 47.45; H, 3.74; N, 3.44.
2-Perfluoropentyl-N-(2-methylphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18b). 5.86 g of 2-methylaniline
15b (5.46 × 10−2 mol) and 2.14 g (2.18 × 10−2 mol) of cyclohexanone 16u were added to a solution
of 9.7 g (1.82 × 10−2 mol) of 14 (RF = C5F11) in 97 mL of dry dichloromethane. The mixture was
stirred for 6 h at reflux. 8.12 g of the title product 18b were obtained, total yield 72%. Spectral data:
1H-NMR (300.13 MHz, CDCl3) δ 1.8 (bs, 2H), 1.9 (s, 3H, CH3), 2.1 (m, 3H), 2.9 (m, 1H), 3.3 (m, 1H),
3.4 (m, 1H), 7.3–7.5 (m, 3 H), 8 (t, J = 7.2 Hz, 1H), 8.2 (d, J = 8.1 Hz, 1H), 8.8 (d, J = 8.1 Hz, 1H);
13C-NMR (75.46MHz, CDCl3) δ 19.9, 21, 26, 29.5, 32.1, 115.2, 126.5, 127.8, 128, 129.5, 136.5, 138 (t, 2JCF
= 24.2 Hz), 148.1, 150.5, 161.1, 163; 19F-NMR (282.4 MHz, DMSO-d6) δ −126.3 (AB system, 2JFF =
285.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.4 (AB system, 2JFF = 285.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3),
−123.1 (AB system, 2JFF = 310 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −121.7 (AB system, 2JFF = 310 Hz,
1F, CF2-CF2-CF2-CF2-CF3), −118.7 (AB system, 2JFF = 299.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −117.6
(AB system, 2JFF = 299.6 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −107.1 (AB system, 2JFF = 290.5 Hz, 1F,
CF2-CF2-CF2-CF2-CF3), −98.2 (AB system, 2JFF = 290.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.2 (m 3F,
CF3). MS (m/z): 492 ([M − I]+, 100). HRMS calcd. for C21H17F11N+: 492.1185, found 492.1190. Anal.
Calcd. for C21H17F11NI: C, 40.73; H, 2.77; N, 2.26. Found: C, 40.75; H, 2.76; N, 2.25.
2-Perfluoropentyl-N-(3-methylphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18c). 6.4 g of 3-methylaniline
15c (5.97 × 10−2 mol) and 2.34 g (2.39 × 10−2 mol) of cyclohexanone 16u were added to a solution of
10.6 g (1.99 × 10−2 mol) of 14 (RF = C5F11) in 53 mL of dry dichloromethane. The mixture was stirred
for 4 h at reflux. 10.2 g of the title product 18c were obtained, total yield 83%. Spectral data: 1H-NMR
(300.13 MHz, CDCl3) δ 1.7 (m, 2H), 1.9 (m, 2H), 2.1 (s, 3H, CH3), 2.9 (m, 2H), 3.5 (m, 2H), 7.5 (s, 1H), 7.6
(m, 3H), 8.2 (d, J = 8.1 Hz, 1H), 8.7 (d, J = 8.1 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 19.8, 21.1, 26.3,
29.5, 31, 117.2, 126.1, 127.8, 128.1, 129.2, 136.8, 138.5 (t, 2JCF = 25.8 Hz), 148.2, 150.5, 163.1; 19F-NMR
(235.3 MHz, CDCl3) δ −126.1 (m 2F, CF2), −122 (m 2F, CF2), −117 (m 2F, CF2), −103.1 (AB system, 2JFF
= 275.6 Hz, 1F, CF2-CF2), −101.2 (AB system, 2JFF = 275.6 Hz, 1F, CF2-CF2), −80.1 (m 3F, CF3). MS
(m/z): 492 ([M − I]+, 100). HRMS calcd. for C21H17F11N+: 492.1185, found 492.1187. Anal. Calcd. for
C21H17F11NI: C, 40.73; H, 2.77; N, 2.26. Found: C, 40.76; H, 2.77; N, 2.27.
2-Perfluoropentyl-N-(4-methylphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18d). 5.74 g of 4-methylaniline
15d (5.35 × 10−2 mol) and 2.1 g (2.14 × 10−2 mol) of cyclohexanone 16u were added to a solution of
9.5 g (1.78 × 10−2 mol) of 14 (RF = C5F11) in 95 mL of dry dichloromethane. The mixture was stirred for
4 h at reflux. 8.84 g of the title product 18d were obtained, total yield 80%. Spectral data: 1H-NMR
(300.13 MHz, CDCl3) δ 1.9 (m, 4H), 2 (s, 3H, CH3), 2.5 (m, 2H), 3.4 (m, 2H), 7.4 (d, J = 8 Hz, 2H), 7.7 (d,
J = 8.1 Hz, 2H), 8.2 (d, J = 8.1 Hz, 1H), 8.7 (d, J = 8.1 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 19.5,
21, 26.2, 29.5, 31.2, 116.2, 125.1, 127, 128.1, 129.2, 135.1, 137.8 (t, 2JCF = 26 Hz), 146, 148.1, 150, 163.1;
19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.5 (m 2F, CF2), −117.5 (m 2F, CF2), −101.2 (m 2F,
CF2), −80.6 (m 3F, CF3). MS (m/z): 492 ([M − I]+, 100). HRMS calcd. for C21H17F11N+: 492.1185, found
492.1189. Anal. Calcd. for C21H17F11NI: C, 40.73; H, 2.77; N, 2.26. Found: C, 40.75; H, 2.78; N, 2.25.
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2-Perfluoropentyl-N-(4-ethylphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18g). 7.24 g of 4-ethylaniline 15g
(5.97 × 10−2 mol) and 2.34 g (2.39 × 10−2 mol) of cyclohexanone 16u were added to a solution of 10.6 g
(1.99 × 10−2 mol) of 14 (RF = C5F11) in 106 mL of dry dichloromethane. The mixture was stirred for
4 h at reflux. 10.72 g of the title product 18g were obtained, total yield 85%. Spectral data: 1H-NMR
(300.13 MHz, CDCl3) δ 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 1.9 (m, 4H), 2.6 (m, 2H), 2.8 (q, J = 8 Hz, 2H,
CH2-CH3), 3.3 (m, 2H), 7.1 (d, J = 8.2 Hz, 2H), 7.7 (d, J = 8.3 Hz, 2H), 8.2 (d, J = 8.1 Hz, 1H), 8.6 (d,
J = 8.1 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 13.1, 19.5, 21, 24.1, 29.5, 31.2, 113.2, 126.1, 127, 129.6,
129.8, 135.1, 138.8 (t, 2JCF = 26.2 Hz), 148.1, 152, 162.9; 19F-NMR (235.3 MHz, CDCl3) δ −126.9 (m 2F,
CF2), −123.5 (m 2F, CF2), −117.5 (m 2F, CF2), −101.8 (m 2F, CF2), −80.6 (m 3F, CF3). MS (m/z): 506 ([M
− I]+, 95). HRMS calcd. for C22H19F11N+: 506.1342, found 506.1346. Anal. Calcd. for C22H19F11NI: C,
41.72; H, 3.02; N, 2.21. Found: C, 41.75; H, 3.04; N, 2.19.
2-Perfluoropentyl-N-(3-chlorophenyl)-5,6,7,8-tetrahydroquinolinium iodide (18i). 7.33 g of 3-chloroaniline
15i (5.75 × 10−2 mol) and 2.25 g (2.3 × 10−2 mol) of cyclohexanone 16u were added to a solution of
10.2 g (1.91 × 10−2 mol) of 14 (RF = C5F11) in 102 mL of dry dichloromethane. The mixture was stirred
for 4 h at reflux. 9.32 g of the title product 18i were obtained, total yield 76%. Spectral data: 1H-NMR
(300.13 MHz, CDCl3) δ 1.7 (m, 2H), 1.9 (m, 2H), 2.9 (m, 2H), 3.5 (m, 2H), 7.4 (s, 1H), 7.5–7.6 (m, 2H),
7.7 (m, 1H), 8.2 (d, J = 8 Hz, 1H), 8.7 (d, J = 8 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 19.6, 21, 26,
29.5, 31.5, 118.2, 127.1, 127.8, 128.1, 130.1, 137.8, 138.8 (t, 2JCF = 24.8 Hz), 147.2, 150.6, 165.6; 19F-NMR
(235.3 MHz, CDCl3) δ −125.6 (m 2F, CF2), −117.6 (m 2F, CF2), −113.5 (m 2F, CF2), −97.9 (AB system,
2JFF = 150.2 Hz, 1F, CF2-CF2), −98.2 (AB system, 2JFF = 150.2 Hz, 1F, CF2-CF2), −79.1 (m 3F, CF3). MS
(m/z): 512 ([M − I]+, 90). HRMS calcd. for C20H14F11NCl+: 512.0639, found 512.0643. Anal. Calcd. for
C20H14F11NICl: C, 37.55; H, 2.21; N, 2.19. Found: C, 37.58; H, 2.22; N, 2.17.
2-Perfluoropentyl-N-(4-methoxyphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18l). 7.36 g of 4-anisidine 15l
(5.97 × 10−2 mol) and 2.34 g (2.39 × 10−2 mol) of cyclohexanone 16u were added to a solution of 10.6 g
(1.99 × 10−2 mol) of 14 (RF = C5F11) in 106 mL of dry dichloromethane. The mixture was stirred for
4 h at reflux. 11.39 g of the title product 18l were obtained, total yield 90%. Spectral data: 1H-NMR
(300.13 MHz, CDCl3) δ 2 (m, 4H), 2.7 (m, 2H), 3.3 (m, 2H), 3.9 (s, 3H, OCH3), 7.1 (d, J = 8.8 Hz, 2H), 7.7
(d, J = 8.6 Hz, 2H), 8.2 (d, J = 8.1 Hz, 1H), 8.8 (d, J = 8.2 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 20.1,
22, 29, 31.1, 56, 117, 125, 127, 128.2, 129.9, 139.5 (t, 2JCF = 27.2 Hz), 146.2, 148.1, 162, 164.5; 19F-NMR
(235.3 MHz, CDCl3) δ −126.9 (m 2F, CF2), −123.5 (m 2F, CF2), −117.5 (m 2F, CF2), −101.7 (m 2F, CF2),
−80.75 (m 3F, CF3). MS (m/z): 508 ([M − I]+, 100). HRMS calcd. for C21H17F11NO+: 508.1134, found
508.1138. Anal. Calcd. for C21H17F11NIO: C, 39.70; H, 2.70; N, 2.20. Found: C, 39.72; H, 2.71; N, 2.19.
2-Perfluoropentyl-N-(phenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19a). 5.24 g of aniline 15a
(5.63 × 10−2 mole) and 2.52 g (2.25 × 10−2 mole) of cycloheptanone 16v were added to a solution of 10
g (1.87 × 10−2 mole) of 14 (RF = C5F11) in 100 mL of dry dichloromethane. The mixture was stirred
for 4 h at reflux. 9.54 g of the title product 19a were obtained, total yield 82%. 1H-NMR (300.13 MHz,
CDCl3) δ 1.7 (m, 2H, CH2, cycloheptyl group), 1.9 (m, 4H, CH2, cycloheptyl group), 3.1 (m, 2H, CH2,
cycloheptyl group), 3.4 (m, 2H, CH2, cycloheptyl group), 7.5–7.7 (m, 5H, Ph-H), 8.2 (d, J = 8.2 Hz, 1H,
Py-H), 8.9 (d, J = 8 Hz, 1H, Py-H); 13C-NMR (75.46MHz, CDCl3) δ 24, 25.3, 30.7, 33.9, 35.4, 124.2, 125.9,
127.7, 129.6, 131.5, 137.7 (t, 2JCF = 27.1 Hz), 146.8, 150.3, 167.4; 19F-NMR (282.4 MHz, CDCl3) δ −126 (m
2F, CF2-CF2 CF2 CF2-CF3), −122.4 (m 2F, CF2-CF2-CF2-CF2-CF3), −117.3 (m 2F, CF2-CF2-CF2-CF2-CF3),
−101.6 (m 2F, CF2-CF2-CF2-CF2-CF3), −80.7 (m 3F, CF2-CF2-CF2 CF2-CF3). MS (m/z): 492 ([M − I]+, 95).
HRMS calcd. for C21H17F11N+ 492.1185, found 492.1190. Anal. Calcd. for C21H17F11NI: C, 40.73; H,
2.77; N, 2.26. Found: C, 40.75; H, 2.78; N, 2.25.
2-Perfluoropentyl-N-(3-methylphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19c). 5.92 g of
3-methylaniline 15c (5.52 × 10−2 mol) and 2.47 g (2.21 × 10−2 mol) of cycloheptanone 16v were
added to a solution of 9.8 g (1.84 × 10−2 mol) of 14 (RF = C5F11) in 98 mL of dry dichloromethane.
The mixture was stirred for 4 h at reflux. 9.68 g of the title product 19c were obtained, total yield
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83%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.7 (m, 2H), 1.9 (m, 4H), 2.45 (s, 3H, CH3), 3
(d, J = 8 Hz, 2H), 3.4 (m, 2H), 7.4 (m, 2H), 7.6 (m, 2H), 8.2 (d, J = 8.4 Hz, 1H), 8.9 (d, J = 8 Hz, 1H);
13C-NMR (75.46MHz, CDCl3) δ 20.7, 21.5, 24.3, 25.3, 30.7, 33.9, 35.7, 122.5, 126.2, 127.7, 129.5, 131, 137.6
(t, 2JCF = 27 Hz), 146.6, 150.2, 167.8; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.5 (m 2F,
CF2), −117 (m 2F, CF2), −101.7 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 506 ([M − I]+, 95). HRMS
calcd. for C22H19F11N+: 506.1342, found 506.1346. Anal. Calcd. for C22H19F11NI: C, 41.72; H, 3.02; N,
2.21. Found: C, 41.75; H, 3.06; N, 2.19.
2-Perfluoropentyl-N-(4-methylphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19d). 6.34 g of
4-methylaniline 15d (5.92 × 10−2 mol) and 2.65 g (2.36 × 10−2 mol) of cycloheptanone 16v were
added to a solution of 10.5 g (1.97 × 10−2 mol) of 14 (RF = C5F11) in 105 mL of dry dichloromethane.
The mixture was stirred for 4 h at reflux. 10.62 g of the title product 19d were obtained, total yield 85%.
Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.6 (m, 2H), 1.9 (m, 4H), 2.4 (s, 3H, CH3), 3 (m, 2H),
3.3 (m, 2H), 7.3 (d, J = 8 Hz, 2H), 7.6 (d, J = 8 Hz, 2H), 8.2 (d, J = 8.4 Hz, 1H), 8.8 (d, J = 8.4 Hz, 1H);
13C-NMR (75.46MHz, CDCl3) δ 20.8, 21.3, 24.2, 25.3, 30.6, 33.9, 35.4, 122.7, 126.6, 127.7, 129.9, 130.2,
135.1, 137.8 (t, 2JCF = 27.1 Hz), 142.5, 146.6, 150.2, 167.7; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F,
CF2), −122.4 (m 2F, CF2), −117.2 (m 2F, CF2), −101.6 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 506 ([M
− I]+, 95). HRMS calcd. for C22H19F11N+: 506.1342, found 506.1348. Anal. Calcd. for C22H19F11NI: C,
41.72; H, 3.02; N, 2.21. Found: C, 41.76; H, 3.05; N, 2.23.
2-Perfluoropentyl-N-(3-ethylphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19f). 6.69 g of
3-ethylaniline 15f (5.52 × 10−2 mol) and 2.47 g (2.21 × 10−2 mol) of cycloheptanone 16v were added to
a solution of 9.8 g (1.84 × 10−2 mol) of 14 (RF = C5F11) in 98 mL of dry dichloromethane. The mixture
was stirred for 4 h at reflux. 10.5 g of the title product 19f were obtained, total yield 88%. Spectral data:
1H-NMR (300.13 MHz, CDCl3) δ 1.2 (t, J = 8 Hz, 3H, CH2-CH3), 1.6 (s, 2H), 1.9 (m, 4H), 2.7 (q, J = 8 Hz,
2H, CH2-CH3), 3 (m, 2H), 3.3 (m, 2H), 7.5 (m, 3 H), 7.6 (m, 1H), 8.2 (d, J = 8.4 Hz, 1H), 8.9 (d, J = 8 Hz,
1H); 13C-NMR (75.46MHz, CDCl3) δ 15.1, 24.3, 25.4, 28.4, 30.6, 33.9, 35.4, 124.1, 125.9, 127.7, 129.6, 131.5,
137.6 (t, 2JCF = 26.7 Hz), 146.7, 150.2, 167.4; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.4
(m 2F, CF2), −117.2 (m 2F, CF2), −102.2 (AB system, 2JFF = 263.3 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −101.1
(AB system, 2JFF = 263.3 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.7 (m 3F, CF3). MS (m/z): 520 ([M − I]+,
100). HRMS calcd. for C23H21F11N+: 520.1498, found 520.1501. Anal. Calcd. for C23H21F11NI: C, 42.68;
H, 3.27; N, 2.16. Found: C, 42.70; H, 3.28; N, 2.14.
2-Perfluoropentyl-N-(4-ethylphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19g). 6.96 g of
4-ethylaniline 15g (5.75 × 10−2 mol) and 2.58 g (2.3 × 10−2 mol) of cycloheptanone 16v were added to a
solution of 10.2 g (1.91 × 10−2 mol) of 14 (RF = C5F11) in 102 mL of dry dichloromethane. The mixture
was stirred for 4 h at reflux. 10.3 g of the title product 19g were obtained, total yield 83%. Spectral
data: 1H-NMR (300.13 MHz, CDCl3) δ 1.3 (t, J = 7.6 Hz, 3H, CH2-CH3), 1.6 (s, 2H), 1.8 (m, 4H), 2.71 (q,
J = 7.6 Hz, 2H, CH2-CH3), 3 (m, 2H), 3.4 (m, 2H), 7.3 (d, J = 8.4 Hz, 2H), 7.6 (d, J = 8.4 Hz, 2H), 8.1
(d, J = 8 Hz, 1H), 8.8 (d, J = 8 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 14.9, 24.2, 25.3, 28.5, 30.6, 33.9,
35.4, 126.7, 127.7, 128.9, 135.2, 137.8 (t, 2JCF = 27.1 Hz), 146.6, 148.6, 150.2, 167.7; 19F-NMR (235.3 MHz,
CDCl3) δ −126.1 (m 2F, CF2), −122.5 (m 2F, CF2), −117.2 (m 2F, CF2), −101.6 (m 2F, CF2), −80.8 (m 3F,
CF3). MS (m/z): 520 ([M − I]+, 100). HRMS calcd. for C23H21F11N+: 520.1498, found 520.1499. Anal.
Calcd. for C23H21F11NI: C, 42.68; H, 3.27; N, 2.16. Found: C, 42.69; H, 3.29; N, 2.15.
2-Perfluoropentyl-N-(3-chlorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19i). 6.4 g of
3-chloroaniline 15i (5.01 × 10−2 mol) and 2.25 g (2.10−2 mol) of cycloheptanone 16v were added
to a solution of 8.9 g (1.67 × 10−2 mol) of 14 (RF = C5F11) in 89 mL of dry dichloromethane. The mixture
was stirred for 4 h at reflux. 7.65 g of the title product 19i were obtained, total yield 70%. Spectral data:
1H-NMR (300.13 MHz, CDCl3) δ 1.6–2.2 (m, 6H), 3.1 (m, 2H), 3.4 (s, 2H), 7.6 (t, J = 8.1 Hz, 1H), 7.7
(d, J = 8.2 Hz, 1H), 7.9 (s, 1H), 8.1 (d, J = 7.9 Hz, 1H), 8.3 (d, J = 8.1 Hz, 1H), 8.9 (d, J = 8.2 Hz, 1H);
13C-NMR (75.46MHz, CDCl3) δ 24.1, 25.2, 30.7, 34, 34.3, 35.5, 127.9, 128.5, 129.8, 136.1, 137.7 (t, 2JCF
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= 26.8 Hz), 138.5, 146.8, 150.5, 167.7; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.4 (m 2F,
CF2), −117.2 (m 2F, CF2), −101.5 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 526 ([M − I]+, 100). HRMS
calcd. for C21H16F11NCl+: 526.0796, found 526.0799. Anal. Calcd. for C21H16F11NICl: C, 38.58; H,
2.47; N, 2.14. Found: C, 38.61; H, 2.48; N, 2.14.
2-Perfluoropentyl-N-(4-chlorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19j). 7.26 g of
4-chloroaniline 15j (5.69 × 10−2 mol) and 2.55 g (2.27 × 10−2 mol) of cycloheptanone 16v were
added to a solution of 10.1 g (1.89 × 10−2 mol) of 14 (RF = C5F11) in 101 mL of dry dichloromethane.
The mixture was stirred for 4 h at reflux. 9.68 g of the title product 19j were obtained, total yield 78%.
Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.7 (m, 2H), 1.9 (m, 4H), 3 (m, 2H), 3.3 (m, 2H), 7.5 (d,
J = 8.8 Hz, 2H), 7.8 (d, J = 8.8 Hz, 2H), 8.2 (d, J = 8 Hz, 1H), 8.8 (d, J = 8.3 Hz, 1H); 13C-NMR (75.46MHz,
CDCl3) δ 24, 25.2, 30.7, 33.9, 34.2, 35.4, 127.9, 128.4, 129.9, 136.1, 137.5 (t, 2JCF = 26.8 Hz), 138.3, 146.8,
150.5, 167.6; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.3 (m 2F, CF2), −117.3 (m 2F, CF2),
−101.5 (m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 526 ([M − I]+, 100). HRMS calcd. for C21H16F11NCl+:
526.0796, found 526.0797. Anal. Calcd. for C21H16F11NICl: C, 38.58; H, 2.47; N, 2.14. Found: C, 38.60;
H, 2.47; N, 2.13.
2-Perfluoropentyl-N-(2-methoxyphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19k). 6.18 g of
2-anisidine 15k (5.01 × 10−2 mol) and 2.25 g (2 × 10−2 mol) of cycloheptanone 16v were added to
a solution of 8.9 g (1.67 × 10−2 mol) of 14 (RF = C5F11) in 45 mL of dry dichloromethane. The
mixture was stirred for 6 h at reflux. 7.6 g of the title product 19k were obtained, total yield 70%.
Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 1.5 (m, 1H), 1.7–2 (m, 4H), 2.1 (m, 1H), 2.9 (m,1H),
3.2–3.5 (m, 3H), 3.8 (s, 3H, OCH3), 7.2 (d, J = 8.3 Hz, 1H), 7.3 (t, J = 7.6 Hz, 1H), 7.7 (t, J = 8.8
Hz, 1H), 8 (s, 1H), 8.3 (d, J = 8.1 Hz, 1H), 9 (d, J = 8.2 Hz, 1H); 13C-NMR (75.46MHz, CDCl3) δ 24,
25.1, 30.7, 34.4, 34.3, 35.6, 127.8, 128.5, 130, 136.1, 137.8 (t, 2JCF = 26.9 Hz), 138.8, 147, 151.5, 167.5;
19F-NMR (282.4 MHz, DMSO-d6) δ −126.5 (AB system, 2JFF = 284.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3),
−125.5 (AB system, 2JFF = 284.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −123 (AB system, 2JFF = 355.2 Hz,
1F, CF2-CF2-CF2-CF2-CF3), −121.8 (AB system, 2JFF = 355.2 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −119.1
(AB system, 2JFF = 380.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −116.5 (AB system, 2JFF = 380.5 Hz, 1F,
CF2-CF2-CF2-CF2-CF3), −107.1 (AB system, 2JFF = 350 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −99.5 (AB
system, 2JFF = 350 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.69 (m 3F, CF3). MS (m/z): 522 ([M − I]+, 100).
HRMS calcd. for C22H19F11NO+: 522.1291, found 522.1297. Anal. Calcd. for C22H19F11NIO: C, 40.70;
H, 2.95; N, 2.16. Found: C, 40.73; H, 2.96; N, 2.16.
2-Perfluoropentyl-N-(4-methoxyphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19l). 6.66 g of
4-anisidine 15l (5.41 × 10−2 mol) and 2.42 g (2.16 × 10−2 mol) of cycloheptanone 16v were added to a
solution of 9.6 g (1.8 × 10−2 mol) of 14 (RF = C5F11) in 96 mL of dry dichloromethane. The mixture was
stirred for 4 h at reflux. 10.31 g of the title product 19l were obtained, total yield 88%. Spectral data:
1H-NMR (300.13 MHz, CDCl3) δ 1.7 (m, 2H), 1.9 (m, 4H), 3 (m, 2H), 3.3 (m, 2H), 3.8 (s, 3H, OCH3),
7 (d, J = 8.8 Hz, 2H), 7.6 (d, J = 8.4 Hz, 2H), 8.1 (d, J = 8.4 Hz, 1H), 8.7 (d, J = 8 Hz, 1H); 13C-NMR
(75.46MHz, CDCl3) δ 24.3, 25.3, 30.7, 33.9, 35.5, 55.8, 114.6, 127.6, 128.2, 130, 138.2, 146.5, 150.2, 161.7,
168.2; 19F-NMR (235.3 MHz, CDCl3) δ −126 (m 2F, CF2), −122.3 (m 2F, CF2), −117.2 (m 2F, CF2), −101.5
(m 2F, CF2), −80.7 (m 3F, CF3). MS (m/z): 522 ([M − I]+, 100). HRMS calcd. for C22H19F11NO+: 522.1291,
found 522.1295. Anal. Calcd. for C22H19F11NIO: C, 40.70; H, 2.95; N, 2.16. Found: C, 40.74; H, 2.95;
N, 2.13.
3.3. General Procedure for the Synthesis of 2-Trifluoromethylated and 2-Perfluoroalkylated
6-Methyl-N-(o-/p-Carboxyphenyl)Pyridinium Iodides (17m–n’),
N-(O-/P-Carboxyphenyl)-5,6,7,8-Tetrahydroquinolinium Iodides (18m–n) and
N-(O-Carboxyphenyl)-6,7,8,9-Tetrahydro-5H-Cyclohepta[b]Pyridinium Iodide (19m)
To a stirred solution of 1-acetoxy-1-iodo-perfluoroalkylethane compounds 14 or 14’ (1 equiv.) in
anhydrous dichloromethane (5 mL DCM for 1 g of 14–14’), was added three equiv. of the corresponding
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aminobenzoic acid 15m–n and 1.2 equiv. of ketone 16t–v. The mixture was stirred under reflux for 12 h
(Tables 1–3) until complete consumption of 14–14’ (monitored by TLC eluent petroleum ether/ethyl
acetate: 80/20 v/v, and 19F-NMR of aliquots). When the reaction was completed, the mixture was
allowed to cool to r.t. then the brown precipitate accumulated during the reaction was separated by
vacuum filtration (it was subsequently identified as anilinium salts by NMR and MS). Then a mixture of
petroleum ether and ethyl ether (40/60 v/v) was added to the filtrate and the corresponding pyridinium
iodides 17m–n’, 18m–n and 19m instantly precipitate and were isolated by vacuum filtration as
amorphous solids.
2-Perfluoropentyl-6-methyl-N-(2-carboxyphenyl)pyridinium iodide (17m). 7.34 g of 2-aminobenzoic acid
15m (5.35 × 10−2 mole) and 1.58 mL or 1.24 g (2.14 × 10−2 mole) of acetone 16t were added to
a solution of 9.5 g (1.78 × 10−2 mole) of 14 (RF = C5F11) in 48 mL of dry dichloromethane. The
mixture was stirred for 12 h at reflux. 5.43 g of the title product 17m were obtained, total yield
50%. 1H-NMR (300.13 MHz, DMSO-d6) δ 2.4 (s, 3H, CH3), 7.7–7.9 (m, 3 H), 8.2 (d, J = 8 Hz, 1H), 8.7
(m, 2H), 9 (t, J = 8 Hz, 1H), 13.9 (bs, 1H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6) δ 22.9 (s, CH3),
127.9, 128.6, 129.4, 132.8, 133.6, 134.4, 137, 139.7 (t, 2JCF = 25.1 Hz), 148.2, 163.4, 165.1 (s, CO2H);
19F-NMR (282.4 MHz, DMSO-d6) δ −126.7 (AB system, 2JFF = 288.7 Hz, 1F, CF2-CF2-CF2-CF2-CF3),
−125.7 (AB system, 2JFF = 288.7 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −122.8 (AB system, 2JFF = 289 Hz,
1F, CF2-CF2-CF2-CF2-CF3), −121.8 (AB system, 2JFF = 289 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −119.2
(AB system, 2JFF = 310.2 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −116.3 (AB system, 2JFF = 310.2 Hz, 1F,
CF2-CF2-CF2-CF2-CF3), −107.5 (AB system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −99.1 (AB
system, 2JFF = 282.5 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.69 (m 3F, CF3). MS (m/z): 482 ([M − I]+, 100).
HRMS calcd. for C18H11F11NO2+ 482.0614, found 482.0622. Anal. Calcd. for C18H11F11INO2: C, 35.49;
H, 1.82; N, 2.30. Found: C, 35.51; H, 1.82; N, 2.33.
2-Trifluoromethyl-6-methyl-N-(2-carboxyphenyl)pyridinium iodide (17m’). 11.02 g of 2-aminobenzoic acid
15m (8.04 × 10−2 mol) and 2.37 mL or 1.86 g (3.21 × 10−2 mol) of acetone 16t were added to a solution
of 8.9 g (2.68 × 10−2 mol) of 14’ (RF = CF3) in 89 mL of dry dichloromethane. The mixture was stirred
for 12 h at reflux. 5.7 g of the title product 17m’ were obtained, total yield 52%. Spectral data: 1H-NMR
(300.13 MHz, DMSO-d6) δ 2.3 (s, 3H, CH3), 7.7–7.8 (m, 3 H), 8 (d, J = 8.1 Hz, 1H), 8.8 (m, 2H), 9 (t,
J = 8 Hz, 1H), 14.2 (bs, 1H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6) δ 21.9 (s, CH3), 118.5 (q, CF3,
1JCF = 280.2 Hz), 127.5 (q, 3JCF = 3.9 Hz), 128, 133.7, 140.2, 140.7, 146, 148.1 (q, C-CF3, 2JCF = 36.6 Hz),
163, 167 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6) δ −60.3 (s 3F, CF3). MS (m/z): 282 ([M − I]+, 100).
HRMS calcd. for C14H11F3NO2+: 282.0742, found 282.0745. Anal. Calcd. for C14H11F3INO2: C, 41.10;
H, 2.71; N, 3.42. Found: C, 41.13; H, 2.72; N, 3.40.
2-Perfluoropentyl-6-methyl-N-(4-carboxyphenyl)pyridinium iodide (17n). 8.27 g of 4-aminobenzoic acid
15n (6.03 × 10−2 mol) and 1.78 mL or 1.39 g (2.41 × 10−2 mol) of acetone 16t were added to a solution
of 10.7 g (2.01 × 10−2 mol) of 14 (RF = C5F11) in 107 mL of dry dichloromethane. The mixture was
stirred for 12 h at reflux. 7.35 g of the title product 17n were obtained, total yield 60%. 1H-NMR (300.13
MHz, DMSO-d6) δ 2.5 (s, 3H, CH3), 8 (d, J = 8.1 Hz, 2H, Ph-H), 8.3 (d, J = 8.1 Hz, 2H, Ph-H), 8.8 (m,
2H, Py-H), 9 (t, J = 8 Hz, 1H, Py-H), 13.8 (bs, 1H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6) δ 22.9 (s,
CH3), 127.1, 128.7, 130.5, 133.8, 139.7, 140.7, 146, 147.6, 163.1, 165.9 (s, CO2H); 19F-NMR (282.4 MHz,
DMSO-d6) δ −125.8 (s 2F, CF2-CF2-CF2-CF2-CF3), −122.3 (s 2F, CF2-CF2-CF2-CF2-CF3), −117.7 (s 2F,
CF2-CF2-CF2-CF2-CF3), −101.8 (s, 2F, CF2-CF2-CF2-CF2-CF3), −80.2 (m 3F, CF2-CF2-CF2-CF2-CF3). MS
(m/z): 482 ([M − I]+, 100). HRMS calcd. for C18H11F11NO2+: 482.0614, found 482.0620. Anal. Calcd.
for C18H11F11INO2: C, 35.49; H, 1.82; N, 2.30. Found: C, 35.52; H, 1.83; N, 2.28.
2-Trifluoromethyl-6-methyl-N-(4-carboxyphenyl)pyridinium iodide (17n’).12.63 g of 4-aminobenzoic acid
15n (9.21 × 10−2 mol) and 2.72 mL or 2.13 g (3.68 × 10−2 mol) of acetone 16t were added to a solution of
10.2 g (3.07 × 10−2 mol) of 14’ (RF = CF3) in 102 mL of dry dichloromethane. The mixture was stirred
for 12 h at reflux. 7.54 g of the title product 17n’ were obtained, total yield 60%. Spectral data: 1H-NMR
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(300.13 MHz, DMSO-d6) δ 2.5 (s, 3H, CH3), 8.1 (d, J = 8 Hz, 2H), 8.3 (d, J = 8 Hz, 2H), 8.7 (m, 2H), 9.1 (t,
J = 8 Hz, 1H), 14 (bs, 1H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6) δ 22.7 (s, CH3), 118 (q, CF3, 1JCF
= 279 Hz), 127.1 (q, 3JCF = 4.2 Hz), 128, 130.4, 133.7, 140, 140.7, 146, 147.6 (q, C-CF3, 2JCF = 35.5 Hz),
163, 166 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6) δ −59.9 (s 3F, CF3). MS (m/z): 282 ([M − I]+, 100).
HRMS calcd. for C14H11F3NO2+: 282.0742, found 282.0747. Anal. Calcd. for C14H11F3INO2: C, 41.10;
H, 2.71; N, 3.42. Found: C, 41.14; H, 2.70; N, 3.40.
2-Perfluoropentyl-N-(2-carboxyphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18m). 7.88 g of 2-aminobenzoic
acid 15m (5.75 × 10−2 mol) and 2.25 g (2.3 × 10−2 mole) of cyclohexanone 16u were added to a solution
of 10.2 g (1.91 × 10−2 mol) of 14 (RF = C5F11) in 51 mL of dry dichloromethane. The mixture was
stirred for 12 h at reflux. 8.96 g of the title product 18m were obtained, total yield 72%. 1H-NMR
(300.13 MHz, CDCl3) δ 1.8 (s, 2H, CH2, cyclohexyl group), 2 (s, 2H, CH2, cyclohexyl group), 2.4 (m, 1H,
CH2, cyclohexyl group), 2.7 (m, 1H, CH2, cyclohexyl group), 3.1 (m, 1H, CH2, cyclohexyl group), 3.3
(m, 1H, CH2, cyclohexyl group), 6.9 (bs, 1H, CO2H), 7.8 (m, 3H, Ph-H), 8.2 (d, J = 7.4 Hz, 1H, Ph-H), 8.4
(d, J = 8.1 Hz, 1H, Py-H), 8.9 (d, J = 8.2 Hz, 1H, Py-H); 1H-NMR (400.13 MHz, DMSO-d6) δ 1.6–1.8 (m,
4H, CH2, cyclohexyl group), 2.3 (m, 1H, CH2, cyclohexyl group), 2.6 (m, 1H, CH2, cyclohexyl group),
3.2 (m, 2H, CH2, cyclohexyl group), 7.8–8 (m, 3H, Ph-H), 8.3 (d, J = 8 Hz, 1H, Ph-H), 8.6 (d, J = 8 Hz,
1H, Py-H), 8.9 (d, J = 8 Hz, 1H, Py-H); 13C-NMR (75.46 MHz, CDCl3) δ 19.9, 21.4, 29.5, 30.5, 126.5, 126.7,
130.6, 132.2, 132.7, 133.2, 136.4, 139.3 (t, 2JCF = 25 Hz), 144.4, 147.5, 161.6, 165.8 (s, CO2H); 13C-NMR
(100.6 MHz, DMSO-d6) δ 20, 21.4, 29.1, 30.3, 127.2 (t, 3JCF = 4 Hz, =C-H, Py), 128.5, 132.6, 133, 134.6,
136.6, 137.2, 137.4 (t, 2JCF = 22.13 Hz, =C-CF2, Py), 144.7, 148, 162.2, 164.9 (s, CO2H); 19F-NMR (282.4
MHz, DMSO-d6) δ −126.5 (AB system, 2JFF = 282 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −125.3 (AB system,
2JFF = 282 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −123 (AB system, 2JFF = 367 Hz, 1F, CF2-CF2-CF2-CF2-CF3),
−121.9 (AB system, 2JFF = 367 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −118.9 (AB system, 2JFF = 338 Hz, 1F,
CF2-CF2-CF2-CF2-CF3), −117 (AB system, 2JFF = 338 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −107 (AB system,
2JFF = 310 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −98.5 (AB system, 2JFF = 310 Hz, 1F, CF2-CF2-CF2-CF2-CF3),
−80.31 (m 3F, CF3). MS (m/z): 522 ([M − I]+, 98). HRMS calcd. for C21H15F11NO2+ 522.0927, found
522.0933. Anal. Calcd. for C21H15F11NIO2: C, 38.85; H, 2.33; N, 2.16. Found: C, 38.88; H, 2.34; N, 2.15.
2-Perfluoropentyl-N-(4-carboxyphenyl)-5,6,7,8-tetrahydroquinolinium iodide (18n). 8.27 g of 4-aminobenzoic
acid 15n (6.03 × 10−2 mol) and 2.36 g (2.41 × 10−2 mol) of cyclohexanone 16u were added to a solution
of 10.7 g (2.01 × 10−2 mol) of 14 (RF = C5F11) in 53.5 mL of dry dichloromethane. The mixture was
stirred for 12 h at reflux. 9.14 g of the title product 18n were obtained, total yield 70%. Spectral data:
1H-NMR (300.13 MHz, CDCl3) δ 2 (m, 4H), 2.6 (m, 2H), 3.4 (m, 2H), 7.9 (d, J = 8 Hz, 2H), 8.2 (d, J = 8 Hz,
2H), 8.8 (d, J = 8.1 Hz, 1H), 9 (d, J = 8.1 Hz, 1H) 12.9 (bs, 1H, CO2H); 13C-NMR (75.46MHz, CDCl3)
δ 20.8, 21, 29.2, 31.5, 125.5, 127, 128.4, 129.5, 133.7, 139.7 (t, 2JCF = 24.3 Hz), 146, 147.2, 163.1, 166 (s,
CO2H); 19F-NMR (235.3 MHz, CDCl3) δ −125.9 (m 2F, CF2), −122.5 (m 2F, CF2), −117.7 (m 2F, CF2),
−101.5 (m 2F, CF2), −80.4 (m 3F, CF3). MS (m/z): 522 ([M − I]+, 90). HRMS calcd. for C21H15F11NO2+:
522.0927, found 522.0931. Anal. Calcd. for C21H15F11NIO2: C, 38.85; H, 2.33; N, 2.16. Found: C, 38.89;
H, 2.34; N, 2.15.
2-Perfluoropentyl-N-(2-carboxyphenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridinium (19m). 8.35 g of
2-aminobenzoic acid 15m (6.09 × 10−2 mol) and 2.73 g (2.43 × 10−2 mole) of cycloheptanone 16v were
added to a solution of 10.8 g (2.03 × 10−2 mole) of 14 (RF = C5F11) in 54 mL of dry dichloromethane.
The mixture was stirred for 6 h at reflux. 9.15 g of the title product 19m were obtained, total yield
68%. 1H-NMR (300.13 MHz, CDCl3) δ 1.4–2 (m, 6H, CH2, cycloheptyl group), 2.7 (m, 1H, CH2,
cycloheptyl group), 3 (m, 1H, CH2, cycloheptyl group), 3.3–3.4 (m, 2H, CH2, cycloheptyl group),
7.7 (bs, 1H, CO2H), 7.77 (m, 3H, Ar-H), 8.1 (d, J = 8 Hz, 1H, Ar-H), 8.3 (d, J = 8 Hz, 1H, Py-H), 8.9
(d, J = 8 Hz, 1H, Py-H); 1H-NMR (300.13 MHz, DMSO-d6) δ 1.4 (m, 1H, CH2, cycloheptyl group),
1.6–1.9 (m, 5H, CH2, cycloheptyl group), 2.8 (m, 2H, CH2, cycloheptyl group), 3.3 (m, 2H, CH2,
cycloheptyl group), 7.9 (m, 2H, Ar-H), 8 (m, 1H, Ar-H), 8.4 (d, J = 6 Hz, 1H, Ar-H), 8.6 (d, J = 6.15
Hz, 1H, Py-H), 8.9 (d, J = 6.18 Hz, 1H, Py-H); 13C-NMR (75.46MHz, DMSO-d6) δ 24, 25.5, 30.4, 33.4,
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35.3, 127.2, 127.5, 129.7, 132.2, 132.6, 132.9, 137.1, 138.2 (t, 2JCF = 20.1 Hz), 147.1, 149.2, 165.1, 166.6;
19F-NMR (282.4 MHz, DMSO-d6) δ −126.6 (AB system, 2JFF = 293.4 Hz, 1F, CF2-CF2-CF2-CF2-CF3),
−125.5 (AB system, 2JFF = 293.4 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −123.4 (AB system, 2JFF = 297.1
Hz, 1F, CF2-CF2-CF2-CF2-CF3), −122.3 (AB system, 2JFF = 297.1 Hz, 1F, CF2-CF2-CF2-CF2-CF3), -119
(AB system, 2JFF = 300.96 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −116.5 (AB system, 2JFF = 300.96 Hz, 1F,
CF2-CF2-CF2-CF2-CF3), −108.2 (AB system, 2JFF = 285.9 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −97.9 (AB
system, 2JFF = 285.9 Hz, 1F, CF2-CF2-CF2-CF2-CF3), −80.86 (m 3F, CF3). MS (m/z): 536 ([M − I]+, 95).
HRMS calcd. for C22H17F11NO2+ 536.1084, found 536.1089. Anal. Calcd. for C22H17F11NIO2: C, 39.84;
H, 2.58; N, 2.11. Found: C, 39.86; H, 2.59; N, 2.10.
3.4. General Procedure for the Synthesis 2-Trifluoromethyl or 2-Perfluoroalkyl-7-Methoxyquinolines 20o–o’
To a stirred solution of 1-acetoxy-1-iodo-perfluoroalkylethane compounds 14 or 14’ (1 equiv.) in
anhydrous dichloromethane (10 mL DCM for 1g of 14–14’), was added 3 equiv. of meta-anisidine 15o.
The mixture was stirred under reflux for the desired time (12 h, Table 4) until complete consumption of
14–14’ (monitored by TLC eluent petroleum ether/ethyl acetate: 80/20 v/v, and 19F-NMR of aliquots).
When the reaction was completed, the mixture was concentrated under reduced pressure and then
stirred with diethyl ether. An excess of petroleum ether was added; the precipitate that had formed
was eliminated by vacuum filtration and washed three times with petroleum ether. The filtrate was
concentrated in vacuo to give a brown oil. Chromatography over silica gel column (eluent, petroleum
ether/ethyl acetate 98/2 v/v) left a yellow oil which was crystallized from methanol/water to give pure
samples of the corresponding quinolines 20o–o’.
3.5. General Procedure for the Synthesis 2-Trifluoromethyl or 2-Perfluoroalkyl-7-Methoxyquinolines 20o–o’ in
the Presence of Ketones 16t–v
To a stirred solution of 1-acetoxy-1-iodo-perfluoroalkylethane compounds 14 or 14’ (1 equiv.) in
anhydrous dichloromethane (10 mL DCM for 1 g of 14–14’), was added three equiv. of meta-anisidine
15o and 1.2 equiv. of ketone 16t–v. The mixture was stirred under reflux for desired time (12 h, Table 4)
until complete consumption of 14–14’ (monitored by TLC eluent petroleum ether/ethyl acetate: 80/20
v/v, and 19F-NMR of aliquots). When the reaction was completed, the mixture was concentrated under
reduced pressure and then stirred with a mixture of petroleum ether/ethyl acetate. Chromatography
over silica gel column (eluent, petroleum ether/ethyl acetate 98/2 v/v) left a yellow oil which was
crystallized from methanol/water to give pure samples of the corresponding quinolines 20o–o’. We were
able to isolate unreacted ketones 16t–v from the corresponding reactions (1.2 equivalent) which were
identified and characterized by NMR and mass spectroscopy
2-Perfluoropentyl-6-methoxyquinoline (20o). 6.25 g of meta-anisidine 15o (5.07 × 10−2 mol) and 2.03 ×
10−2 mole of the corresponding ketone (1.17 g of acetone 16t or 1.99 g of cyclohexanone 16u or 2.27 g of
cylcoheptanone 16v) were added to a solution of 9 g (1.69 × 10−2 mole) of 14 (RF = C5F11) in 90 mL
of dry dichloromethane. The mixture was stirred for 12 h at reflux. In the presence of acetone: 6.1 g
of 20o (85% yield) and 0.5 g of 16t. Or in the presence of cyclohexanone: 5.9 g of 20o (82% yield)
and 1.9 g of 16u. Or in the case of cycloheptanone: 5.9 g of 20o (82% yield) and 2.25 g of 16u were
obtained respectively.
Or 6.8 g of meta-anisidine 15o (5.52 × 10−2 mol) were added to a solution of 9.8 g (1.84 ×10−2 mol) of
14 (RF = C5F11) in 98 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 6.6 g
(84% yield) of quinoline 20o were obtained respectively. 1H-NMR (300.13 MHz, CDCl3) δ 3.8 (s, 3H,
OCH3), 7.5 (d, J = 8.5 Hz, 1H), 7.8 (d, J = 8.6 Hz, 1H), 8 (m, 2H), 8.6 (d, J = 8.6 Hz, 1H); 13C-NMR
(75.46 MHz, CDCl3) δ 55.6 (s, OCH3), 117.6, 126.5, 130.5, 130.7, 135.2, 138.7, 139.8, 146.3, 147.8 (t, 2JCF =
26 Hz, C-CF2); 19F-NMR (282.4 MHz, CDCl3) δ −126.5 (m 2F, CF2-CF2-CF2-CF2-CF3), −122.5 (m 2F,
CF2-CF2-CF2-CF2-CF3), −122 (m 2F, CF2-CF2-CF2-CF2-CF3), −114.5 (m, 2F, CF2-CF2-CF2-CF2-CF3),
−81.2 (m 3F, CF2-CF2-CF2-CF2-CF3). MS (m/z): 428 [M + H]+. HRMS m/z [M + H]+ calcd. for
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C15H9F11NO+: 428.0508, found: 428.0510. Anal calcd. for C15H8F11NO: C, 42.17; H, 1.89; N, 3.28,
found: C, 42.19; H, 1.88; N, 3.26.
2-Trifluoromethyl-6-methoxyquinoline (20o’). 10.9 g of 3-anisidine 15o (8.85 × 10−2 mol) and 2.6 mL or 2 g
(3.54 × 10−2 mol) of acetone 16t were added to a solution of 9.8 g (2.95 × 10−2 mol) of 14’ (R’F = C2F5)
in 98 mL of dry dichloromethane. The mixture was stirred for 12 h at reflux. 5.9 g of the quinoline 20o’
were obtained, total yield 88%. Spectral data: 1H-NMR (300.13 MHz, CDCl3) δ 3.8 (s, 3H, OCH3), 7.6
(d, J = 8.4 Hz, 1H), 7.8 (d, J = 8.5 Hz, 1H), 7.9–8 (m, 2H), 8.5 (d, J = 8.5 Hz, 1H); 13C-NMR (75.46 MHz,
CDCl3) δ 55.5 (s, OCH3), 116.5 (q, 3JCF = 2.1 Hz, CH-C-CF3), 122.8 (q, 1JCF = 275.6 Hz, CF3), 128, 128.5,
129.3, 132.1, 136, 139.1, 142.6, 148.5 (q, 2JCF = 34 Hz, C-CF3); 19F-NMR (282.4 MHz, CDCl3) δ − 67.8
(m 3F, CF3). MS (m/z): 228 [M + H]+. HRMS m/z [M + H]+ calcd. for C11H9F3NO+: 228.0636, found:
228.0643. Anal calcd. for C11H8F3NO: C, 58.15; H, 3.55; N, 6.17, found: C, 58.17; H, 3.56; N, 6.15.
3.6. General Procedure for the Preparation and Isolation of 2-Perfluoroalkyl- and
2-Trifluoromethyl-1-(R-phenyl)amino-3-(R-phenyl)iminopropene Intermediates 21a–l (all examples except R =
CO2H or R = m-OMe)
A mixture of one equivalent of gem-iodoacetate compounds 14 or 14’ or 14” and two equivalents
of the corresponding anilines 15a–l in dichloromethane (10 mL DCM for 1 g of 14–14”) was stirred
at room temperature until disappearance of 19F-NMR signals corresponding to the starting products
14–14” (2–6 h). At the end of the reaction, a solution of 10% sodium thiosulfate was added to the
reaction mixture and the product was extracted three times with ether. The combined extracts were
washed several times with aqueous 0.5 M hydrochloric solution, dried over anhydrous sodium sulfate
and concentrated under reduced pressure to give a bright yellow oil. Chromatography over silica
gel column (eluent: petroleum ether/ethyl acetate 98/2 v/v) yielded the pure compounds 21a–l as
yellow liquids.
3-Perfluoropenthyl-1-phenylamino-3-phenyliminopropene (21a). 3.49 g of aniline 15a (3.75 × 10−2 mol) were
added to a solution of 10 g (1.87 × 10−2 mol) of 14 (RF = C5F11) in 100 mL of dry dichloromethane.
The mixture was stirred for 4 h at room temperature. 8.28 g of the title product 21a were obtained, total
yield 90%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21a) δ 5.5 (d, 3JHH = 13 Hz, 1H, CH=CH-NH), 6.8 (t
(AB system), J = 8.7 Hz, 4Hortho, Ph-H), 6.9 (t, J = 7.4 Hz, 1Hpara, Ph-H), 7.1 (t, J = 7.4 Hz, 1Hpara, Ph-H),
7.2 (t, J = 8.1 Hz, 2Hmeta, Ph-H), 7.4 (t, J = 7.8 Hz, 2Hmeta, Ph-H), 7.45 (m, 1H, CH=CH-NH), 9.9 (d, 3JHNH
= 12.8 Hz, CH=CH-NH); 1H-NMR (300.13 MHz, DMSO-d6/D2O, EEE-21a) δ 5.4 (d, 3JHH = 13 Hz, 1H,
CH=CH-NH), 6.7 (d, J = 8.5 Hz, 4Hortho, Ph-H), 6.9 (t, J = 7.5 Hz, 1Hpara, Ph-H), 7.1 (t, J = 7.4 Hz, 1Hpara,
Ph-H), 7.2 (t, J = 8 Hz, 2Hmeta, Ph-H), 7.4 (t, J = 8 Hz, 2Hmeta, Ph-H), 7.45 (m, 1H, CH=CH-NH); 13C-NMR
(75.46 MHz, DMSO-d6, EEE-21a) δ 91.5, 114.6, 118.5, 122.1, 123.5, 129.1, 129.5, 130, 140.5, 141.5 (t,
3JCF = 5.4 Hz, CF2-(C=N)-CH=CH-NH), 149.9, 153.6 (t, 2JC1F = 22.5 Hz, CF2-(C=N)-CH=CH-NH);
19F-NMR (282.4 MHz, DMSO-d6, EEE-21a) δ −80.2 (t, J = 8.4 Hz, 3F, CF2-CF2-CF2-CF2-CF3), −109.5 (t,
J = 11 Hz, 2F, CF2-CF2-CF2-CF2-CF3), −120.4 (m, 2F, CF2-CF2-CF2-CF2-CF3), −121 (q, J = 5.6 Hz, 2F,
CF2-CF2-CF2-CF2-CF3), −125.8 (t, J = 11.2 Hz, 2F, CF2-CF2-CF2-CF2-CF3). MS (m/z): 491 [M + H]+.
HRMS calcd. for C20H14F11N2+: 491.0981, found: 491.0985; Anal calcd. for C20H13F11N2: C, 48.99; H,
2.67; N, 5.71, found C, 48.97; H, 2.66; N, 5.74.
3-Trifluoromethyl-1-phenylamino-3-phenyliminopropene (21a’). 3.64 g of aniline 15a (3.91 × 10−2 mol) were
added to a solution of 6.5 g (1.95 × 10−2 mol) of 14’ (RF = CF3) in 65 mL of dry dichloromethane.
The mixture was stirred for 3 h at room temperature. 4.65 g of the title product 21a’ were obtained,
total yield 82%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21a’) δ 5.5 (d, J = 13.7 Hz, 1H, CH=CH-NH),
6.8 (d, J = 7.5 Hz, 2H), 7 (m, 3H), 7.15 (t, J = 7.4 Hz, 1H), 7.3 (t, J = 7.8 Hz, 2H), 7.4 (t, J = 7.7 Hz, 2H), 7.6
(t, J = 13 Hz, 1H, CH=CH-NH), 9.9 (d, J = 12.3 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6,
EEE-21a’) δ 90.8, 115.1, 119.4, 120.5 (q, CF3, 1JCF = 279.2 Hz), 122.2, 123.5, 129.1, 129.5, 140.64, 140.8
(q, 3JCF = 3 Hz, CF3-(C=N)-CH=CH-NH), 149.5, 153.3 (q, 2JCF = 30.5 Hz, CF3-(C=N)-CH=CH-NH);
19F-NMR (282.4 MHz, DMSO-d6, EEE-21a’) δ −65.7 (s, 3F). MS (m/z): 291 [M + H]+. HRMS calcd.
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for C16H14F3N2+: 291.1109, found 291.1110. Anal. Calcd. for C16H13F3N2: C, 66.20; H, 4.51; N, 9.65.
Found: C, 66.19; H, 4.48; N, 9.55.
3-Perfluoropropyl-1-phenylamino-3-phenyliminopropene (21a”). 2.36 g of aniline 15a (2.54 × 10−2 mol) were
added to a solution of 5.5 g (1.27 × 10−2 mol) of 14” (RF = C3F7) in 55 mL of dry dichloromethane.
The mixture was stirred for 3 h at room temperature. 4.22 g of the title product 21a” were obtained,
total yield 85%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21a”) δ 5.5 (d, J = 13.5 Hz, 1H, CH=CH-NH),
6.8 (d, J = 7.4 Hz, 2H), 7 (m, 3H), 7.2 (t, J = 7.4 Hz, 1H), 7.3 (t, J = 7.7 Hz, 2H), 7.4 (t, J = 7.7 Hz, 2H),
7.7 (t, J = 13.1 Hz, 1H, CH=CH-NH), 9.9 (d, J = 12.1 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz,
DMSO-d6, EEE-21a”) δ 90.5, 115, 118.5, 122, 123.5, 129.3, 129.7, 130, 140.5, 141 (t, 3JCF = 5 Hz,
CF2-(C=N)-CH=CH-NH), 150, 153.6 (t, 2JCF = 21.5 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz,
DMSO-d6, EEE-21a”) δ −80.5 (m, 3F), −109.1 (t, J = 11 Hz, 2F), −126 (m, 2F). MS (m/z): 391 [M + H]+.
HRMS calcd. for C18H14F7N2+: 391.1045, found: 391.1055; Anal calcd. for C18H13F7N2: C, 55.39; H,
3.36; N, 7.18, found C, 55.41; H, 3.35; N, 7.15.
3-Perfluoropentyl-1-(2-methylphenylamino)-3-(2-methylphenylimino)-propene (21b). 3.26 g of
2-methylaniline 15b (3.04 × 10−2 mol) were added to a solution of 8.1 g (1.52 × 10−2 mol) of 14
(RF = C5F11) in 81 mL of dry dichloromethane. The mixture was stirred for 6 h at room temperature.
5.52 g of the title product 21b were obtained, total yield 70%. 1H-NMR (300.13 MHz, DMSO-d6,
EEE-21b) δ 2.1 (s, 3H), 2.3 (s, 3H), 5.6 (d, J = 13.1 Hz, CH=CH-NH), 6.5–7.3 (m, 8H, HAr), 7.6 (m, 1H,
CH=CH-NH), 9.3 (bs, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21b) δ 18.8, 18.9, 89,
113.1, 117.7, 121.5, 123.5, 129, 129.3, 130, 140.5, 141.5 (t, 3JCF = 4.8 Hz, CF2-(C=N)-CH=CH-NH), 150.1,
153.5 (t, 2JC1F = 20.5 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21b) δ −80.5
(m, 3F), −109 (m, 2F), −120.5 (m, 2F), −121 (m, 2F), −125.5 (m, 2F). MS (m/z): 519 [M + H]+. HRMS
calcd. for C22H18F11N2+: 519.1294, found: 519.1298; Anal calcd. for C22H17F11N2: C, 50.97; H, 3.31; N,
5.40, found C, 50.99; H, 3.30; N, 5.37.
3-Perfluoropentyl-1-(3-methylphenylamino)-3-(3-methylphenylimino)-propene (21c). 3.22 g of 3-methylaniline
15c (3.10−2 mol) were added to a solution of 8 g (1.5 × 10−2 mol) of 14 (RF = C5F11) in 80 mL of dry
dichloromethane. The mixture was stirred for 4 h at room temperature. 6.23 g of the title product 21c
were obtained, total yield 80%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21c) δ 2.2 (s, 3H), 2.3 (s, 3H), 5.4
(d, J = 13.6 Hz, 1H, CH=CH-NH), 6.6 (m, 2H), 6.7 (m, 3H), 6.9 (d, J = 7.6 Hz, 1H), 7.1 (m, 1H), 7.2 (t,
J = 7.6 Hz, 1H), 7.5 (t, J = 12.5 Hz, 1H, CH=CH-NH), 9.7 (d, J = 12.5 Hz, 1H, CH=CH-NH); 13C-NMR
(75.46 MHz, DMSO-d6, EEE-21c) δ 20.5, 20.9, 89, 113.5, 117.5, 121.5, 123.5, 129, 129.5, 130.2, 140, 141.1
(t, 3JCF = 5.3 Hz, CF2-(C=N)-CH=CH-NH), 150, 153 (t, 2JC1F = 21.5 Hz, CF2-(C=N)-CH=CH-NH);
19F-NMR (282.4 MHz, DMSO-d6, EEE-21c) δ −80.5 (m, 3F), −109.6 (m, 2F), −120.2 (m, 2F), −121.5
(m, 2F), −125.5 (m, 2F). MS (m/z): 519 [M + H]+. HRMS calcd. for C22H18F11N2+: 519.1294, found:
519.1295; Anal calcd. for C22H17F11N2: C, 50.97; H, 3.31; N, 5.40, found C, 50.99; H, 3.28; N, 5.38
3-Perfluoropentyl-1-(4-methylphenylamino)-3-(4-methylphenylimino)-propene (21d). 3.62 g of
4-methylaniline 15d (3.38 × 10−2 mol) were added to a solution of 9 g (1.69 × 10−2 mol) of 14
(RF = C5F11) in 90 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature.
7.71 g of the title product 21d were obtained, total yield 88%. 1H-NMR (300.13 MHz, DMSO-d6,
EEE-21d) δ 2.2 (s, 3H), 2.3 (s, 3H), 5.4 (d, J = 13 Hz, 1H, CH=CH-NH), 6.7 (d, J = 8 Hz, 2H), 6.8 (d,
J = 8.2 Hz, 2H), 7.1 (d, J = 8.2 Hz, 2H), 7.2 (d, J = 8 Hz, 2H), 7.5 (t, J = 12.5 Hz, 1H, CH=CH-NH), 9.7
(d, J = 12.4 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21d) δ 20.1, 20.4, 90.2, 115.5,
117.5, 122, 124.5, 129.2, 129.5, 140, 141.9 (t, 3JCF = 3.5 Hz, CF2-(C=N)-CH=CH-NH), 150.5, 152.9 (t,
2JC1F = 31.1 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21d) δ −80.3 (m, 3F),
−109.5 (m, 2F), −120.1 (m, 2F), −121.5 (m, 2F), −125 (m, 2F). MS (m/z): 519 [M + H]+. HRMS calcd.
for C22H18F11N2+: 519.1294, found: 519.1290; Anal calcd. for C22H17F11N2: C, 50.97; H, 3.31; N, 5.40,
found C, 50.97; H, 3.29; N, 5.42
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3-Trifluoromethyl-1-(4-methylphenylamino)-3-(4-methylphenylimino)-propene (21d’). 5.48 g of
4-methylaniline 15d (5.12 × 10−2 mol) were added to a solution of 8.5 g (2.56 × 10−2 mol) of 14’
(RF = CF3) in 85 mL of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 7 g
of the title product 21d’ were obtained, total yield 86%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21d’) δ
2.2 (s, 3H), 2.3 (s, 3H), 5.4 (d, J = 13.8 Hz, 1H, CH=CH-NH), 6.7 (d, J = 8 Hz, 2H), 6.8 (d, J = 8.2 Hz,
2H), 7.1 (d, J = 8.2 Hz, 2H), 7.2 (d, J = 8 Hz, 2H), 7.5 (t, J = 12.9 Hz, 1H, CH=CH-NH), 9.7 (d,
J = 12.4 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21d’) δ 20.1, 20.3, 90.4, 115, 119.1,
120.6 (q, 1JCF = 279.5 Hz, CF3), 129.1, 129.7, 129.9, 130.8, 131.1, 132.5, 138.2, 140.8 (q, 3JCF = 3.1 Hz,
CF3-(C=N)-CH=CH-NH), 147, 153.4 (q, 2JCF = 30.8 Hz, CF3-(C=N)-CH=CH-NH); 19F-NMR (282.4
MHz, DMSO-d6, EEE-21d’) δ −65.7 (s, 3F). MS (m/z): 319 [M + H]+. HRMS calcd. for C18H18F3N2+:
319.1422, found: 319.1425; Anal calcd. for C18H17F3N2: C, 67.91; H, 5.38; N, 8.80, found C, 67.95; H,
5.37; N, 8.82.
3-Perfluoropentyl-1-(2-ethylphenylamino)-3-(2-ethylphenylimino)-propene (21e). 3.59 g of 2-ethylaniline 15e
(2.96 × 10−2 mol) were added to a solution of 7.9 g (1.48 × 10−2 mol) of 14 (RF = C5F11) in 79 mL of
dry dichloromethane. The mixture was stirred for 6 h at room temperature. 5.43 g of the title product
21e were obtained, total yield 67%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21e) δ 1.2 (t, J = 8 Hz,
3H, CH2-CH3), 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.5 (q, J = 8 Hz, 2H, CH2-CH3), 2.7(q, J = 8 Hz, 2H,
CH2-CH3), 5.6 (d, J = 12.8 Hz, CH=CH-NH), 6.5–7.3 (m, 8H, HAr), 7.5 (m, 1H, CH=CH-NH), 9.1 (bs,
1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21e) δ 13.2 (s, CH2-CH3), 13.3 (s, CH2-CH3),
24.1 (s, CH2-CH3), 24.3 (s, CH2-CH3), 89, 112.9, 117.5, 121.2, 129.3, 129.4, 130.5, 140.5, 141 (t, 3JCF =
4.9 Hz, CF2-(C=N)-CH=CH-NH), 149.9, 153.1 (t, 2JC1F = 21.5 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR
(282.4 MHz, DMSO-d6, EEE-21e) δ −80.6 (m, 3F), −109.2 (m, 2F), −120.1 (m, 2F), −121.1 (m, 2F), −125
(m, 2F). MS (m/z): 547 [M + H]+. HRMS calcd. for C24H22F11N2+: 547.1607, found: 547.1610; Anal
calcd. for C24H21F11N2: C, 52.75; H, 3.87; N, 5.13, found C, 52.76; H, 3.88; N, 5.10.
3-Perfluoropentyl-1-(3-ethylphenylamino)-3-(3-ethylphenylimino)-propene (21f). 3.87 g of 3-ethylaniline 15f
(3.19 × 10−2 mol) were added to a solution of 8.5 g (1.59 × 10−2 mol) of 14 (RF = C5F11) in 85 mL of
dry dichloromethane. The mixture was stirred for 4 h at room temperature. 6.71 g of the title product
21f were obtained, total yield 77%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21f) δ 1.1 (t, J = 8 Hz, 3H,
CH2-CH3), 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.6 (q, J = 8 Hz, 2H, CH2-CH3), 2.7 (q, J = 8 Hz, 2H, CH2-CH3),
5.4 (d, J = 13.1 Hz, 1H, CH=CH-NH), 6.6–6.8 (m, 5H), 6.9 (d, J = 7.5 Hz, 1H), 7.1 (m, 1H), 7.2 (t, J = 7.6 Hz,
1H), 7.5 (t, J = 12.5 Hz, 1H, CH=CH-NH), 9.6 (d, J = 12.8 Hz, 1H, CH=CH-NH); 13C-NMR (75.46 MHz,
DMSO-d6, EEE-21f) δ 13.1 (s, CH2-CH3), 13.3 (s, CH2-CH3), 24 (s, CH2-CH3), 24.3 (s, CH2-CH3), 90.2,
114.1, 117.8, 122, 123.1, 129, 129.2, 130.2, 140, 141.1 (t, 3JCF = 5.9 Hz, CF2-(C=N)-CH=CH-NH), 151.1,
153.5 (t, 2JC1F = 22.1 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21f) δ −81.5
(m, 3F), −109.1 (m, 2F), −120.2 (m, 2F), −121.5 (m, 2F), −126.1 (m, 2F). MS (m/z): 547 [M + H]+. HRMS
calcd. for C24H22F11N2+: 547.1607, found: 547.1611; Anal calcd. for C24H21F11N2: C, 52.75; H, 3.87; N,
5.13, found C, 52.78; H, 3.88; N, 5.14.
3-Perfluoropentyl-1-(4-ethylphenylamino)-3-(4-ethylphenylimino)-propene (21g). 4 g of 4-ethylaniline 15g
(3.3 × 10−2 mol) were added to a solution of 8.8 g (1.65 × 10−2 mol) of 14 (RF = C5F11) in 88 mL of dry
dichloromethane. The mixture was stirred for 4 h at room temperature. 7.67 g of the title product
21g were obtained, total yield 85%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21g) δ 1.2 (t, J = 8 Hz,
3H, CH2-CH3), 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.6 (q, J = 8 Hz, 2H, CH2-CH3), 2.7 (q, J = 8 Hz, 2H,
CH2-CH3), 5.6 (d, J = 13.4 Hz, 1H, CH=CH-NH), 6.6 (d, J = 8.1 Hz, 2H), 6.8 (d, J = 8.2 Hz, 2H), 7.1
(d, J = 8.2 Hz, 2H), 7.2 (d, J = 8.1 Hz, 2H), 7.5 (t, J = 12.8 Hz, 1H, CH=CH-NH), 9.6 (d, J = 12.7 Hz,
1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21g) δ 13.3 (s, CH2-CH3), 13.4 (s, CH2-CH3),
24.3 (s, CH2-CH3), 24.5 (s, CH2-CH3), 90.2, 115.5, 117.5, 123.1, 125.2, 129.1, 129.3, 140.5, 141.9 (t, 3JCF =
4.2 Hz, CF2-(C=N)-CH=CH-NH), 151.5, 153.4 (t, 2JC1F = 32.2 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR
(282.4 MHz, DMSO-d6, EEE-21g) δ −80.7 (m, 3F), −109.5 (m, 2F), −120.7 (m, 2F), −122.4 (m, 2F), −125.8
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(m, 2F). MS (m/z): 547 [M + H]+. HRMS calcd. for C24H22F11N2+: 547.1607, found: 547.1609; Anal
calcd. for C24H21F11N2: C, 52.75; H, 3.87; N, 5.13, found C, 52.77; H, 3.87; N, 5.14.
3-Trifluoromethyl-1-(4-ethylphenylamino)-3-(4-ethylphenylimino)-propene (21g’). 6.56 g of 4-ethylaniline
15g (5.42 × 10−2 mol) were added to a solution of 9 g (2.71 × 10−2 mol) of 14’ (RF = CF3) in 90 mL of
dry dichloromethane. The mixture was stirred for 4 h at room temperature. 7.97 g of the title product
21g’ were obtained, total yield 85%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21g’) δ 1.2 (t, J = 7.8 Hz,
3H, CH2-CH3), 1.3 (t, J = 8 Hz, 3H, CH2-CH3), 2.5 (q, J = 7.9 Hz, 2H, CH2-CH3), 2.7 (q, J = 8.1 Hz, 2H,
CH2-CH3), 5.5 (d, J = 13.6 Hz, 1H, CH=CH-NH), 6.7 (d, J = 7.9 Hz, 2H), 6.8 (d, J = 8 Hz, 2H), 7.1 (d,
J = 8.1 Hz, 2H), 7.2 (d, J = 8 Hz, 2H), 7.5 (t, J = 12.5 Hz, 1H, CH=CH-NH), 9.6 (d, J = 12.4 Hz, 1H,
CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21g’) δ 13.3 (s, CH2-CH3), 13.4 (s, CH2-CH3),
24.3 (s, CH2-CH3), 24.5 (s, CH2-CH3), 90.6, 116.2, 120.1, 120.5 (q, 1JCF = 280.5 Hz, CF3), 129.7, 129.9,
130.8, 131, 132.5, 138.3, 140.8 (q, 3JCF = 4.2 Hz, CF3-(C=N)-CH=CH-NH), 147.5, 153.1 (q, 2JCF = 29.9 Hz,
CF3-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21g’) δ −65.5 (s, 3F). MS (m/z): 347
[M + H]+. HRMS calcd. for C20H22F3N2+: 347.1735, found: 347.1740; Anal calcd. for C20H21F3N2: C,
69.35; H, 6.11; N, 8.09, found C, 69.41; H, 6.10; N, 8.11.
3-Perfluoropentyl-1-(2-chlorophenylamino)-3-(2-chlorophenylimino)-propene (21h). 4.84 g of 2-chloroaniline
15h (3.79 × 10−2 mol) were added to a solution of 10.1 g (1.89 × 10−2 mol) of 14 (RF = C5F11) in 101 mL
of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 6.57 g of the title product
21h were obtained, total yield 62%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21h) δ 5.6 (d, J = 13.8 Hz, 1H,
CH=CH-NH), 6.9 (d, J = 7.71 Hz, 1HAr), 7.1–7.4 (m, 7HAr), 7.5 (d, J = 7.9 Hz, 1H, CH=CH-NH), 9.5 (bs,
1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21h) δ 90.1, 114.2, 115.1, 117.1, 121.2, 129.3,
129.4, 130.5, 140.5, 149.9, 153.2 (t, 2JC1F = 29.8 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz,
DMSO-d6, EEE-21h) δ −80.6 (m, 3F), −109.5 (m, 2F), −120.3 (m, 2F), −121.1 (m, 2F), −125 (m, 2F). MS
(m/z): 560 [M + H]+. HRMS calcd. for C20H12Cl2F11N2+: 559.0202, found: 559.0210; Anal calcd. for
C20H11Cl2F11N2: C, 42.96; H, 1.98; N, 5.01, found C, 42.95; H, 1.96; N, 5.10.
3-Perfluoropentyl-1-(3-chlorophenylamino)-3-(3-chlorophenylimino)-propene (21i). 4.79 g of 3-chloroaniline
15i (3.75 × 10−2 mol) were added to a solution of 10 g (1.87 × 10−2 mol) of 14 (RF = C5F11) in 100 mL of
dry dichloromethane. The mixture was stirred for 4 h at room temperature. 7.35 g of the title product
21i were obtained, total yield 70%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21i) δ 5.6 (d, J = 13.6 Hz, 1H,
CH=CH-NH), 6.7–6.9 (m, 6H), 7.2–7.3 (m, 2H), 7.5 (t, J = 13.2 Hz, 1H, CH=CH-NH), 9.7 (d, J = 12.8 Hz,
1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21i) δ 90.4, 112.2, 115.1, 116.4, 117.1, 121.4,
129.1, 129.5, 130.6, 141.5, 150.2, 153.2 (t, 2JC1F = 30.2 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz,
DMSO-d6, EEE-21i) δ −80.5 (m, 3F), −109.1 (m, 2F), −120.1 (m, 2F), −121.1 (m, 2F), −125 (m, 2F). MS
(m/z): 560 [M + H]+. HRMS calcd. for C20H12Cl2F11N2+: 559.0202, found: 559.0205; Anal calcd. for
C20H11Cl2F11N2: C, 42.96; H, 1.98; N, 5.01, found C, 42.98; H, 1.97; N, 5.00.
3-Perfluoropentyl-1-(4-chlorophenylamino)-3-(4-chlorophenylimino)-propene (21j). 4.6 g of 4-chloroaniline
15j (3.6 × 10−2 mol) were added to a solution of 9.6 g (1.8 × 10−2 mol) of 14 (RF = C5F11) in 96 mL
of dry dichloromethane. The mixture was stirred for 4 h at room temperature. 7.76 g of the title
product 21j were obtained, total yield 77%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21j) δ 5.4 (d,
J = 13.6 Hz, 1H, CH=CH-NH), 6.8 (d, J = 8 Hz, 2H), 7 (d, J = 8.1 Hz, 2H), 7.3 (d, J = 8.2 Hz, 2H), 7.4 (d,
J = 8 Hz, 2H), 7.6 (t, J = 13.2 Hz, 1H, CH=CH-NH), 9.8 (d, J = 12.9 Hz, 1H, CH=CH-NH); 13C-NMR
(75.46 MHz, DMSO-d6, EEE-21j) δ 90.3, 116.1, 117.5, 123, 125.2, 129.2, 129.3, 140.6, 141.5 (t, 3JCF = 5.1
Hz, CF2-(C=N)-CH=CH-NH), 151.6, 153.5 (t, 2JC1F = 31.1 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR
(282.4 MHz, DMSO-d6, EEE-21j) δ −80.6 (m, 3F), −109.2 (m, 2F), −120.5 (m, 2F), −122.5 (m, 2F), −125.2
(m, 2F). MS (m/z): 560 [M + H]+. HRMS calcd. for C20H12Cl2F11N2+: 559.0202, found: 559.0209; Anal
calcd. for C20H11Cl2F11N2: C, 42.96; H, 1.98; N, 5.01, found C, 42.99; H, 1.98; N, 5.03.
3-Perfluoropentyl-1-(2-methoxyphenylamino)-3-(2-methoxyphenylimino)-propene (21k). 3.93 g of
2-methoxyaniline 15k (3.19 × 10−2 mol) were added to a solution of 8.5 g (1.59 × 10−2 mol) of
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14 (RF = C5F11) in 85 mL of dry dichloromethane. The mixture was stirred for 6 h at room temperature.
5.97 g of the title product 21k were obtained, total yield 68%. 1H-NMR (300.13 MHz, DMSO-d6,
EEE-21k) δ 3.7 (s, 3H, OCH3), 3.8 (s, 3H, OCH3), 5.5 (d, J = 12.8 Hz, CH=CH-NH), 6.5–7.4 (m, 8H, HAr),
7.5 (m, 1H, CH=CH-NH), 9.1 (bs, 1H, CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21k) δ
55.5 (s, OCH3), 55.6 (s, OCH3), 89.2, 112.5, 116.9, 120.8, 129.1, 129.2, 130.2, 132.1, 140.6, 141.2 (t, 3JCF =
4.5 Hz, CF2-(C=N)-CH=CH-NH), 149.2, 152.9 (t, 2JC1F = 20.1 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR
(282.4 MHz, DMSO-d6, EEE-21k) δ −80.6 (m, 3F), −109.1 (m, 2F), −120.1 (m, 2F), −121.3 (m, 2F), −125.5
(m, 2F). MS (m/z): 551 [M + H]+. HRMS calcd. for C22H18F11N2O2+: 551.1193, found: 551.1199; Anal
calcd. for C22H17F11N2O2: C, 48.01; H, 3.11; N, 5.09, found C, 48.08; H, 3.10; N, 5.11.
3-Perfluoropentyl-1-(4-methoxyphenylamino)-3-(4-methoxyphenylimino)-propene (21l). 4.25 g of 4-anisidine
15l (3.45 × 10−2 mol) were added to a solution of 9.2 g (1.72 × 10−2 mol) of 14 (RF = C5F11) in 92 mL of
dry dichloromethane. The mixture was stirred for 4 h at room temperature. 6.84 g of the title product
21l were obtained, total yield 72%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21l) δ 3.7 (s, 3H, OCH3), 3.8
(s, 3H, OCH3), 5.6 (d, J = 13.1 Hz, 1H, CH=CH-NH), 6.6 (d, J = 7.9 Hz, 2H), 6.8 (d, J = 8 Hz, 2H), 7.1
(d, J = 8 Hz, 2H), 7.2 (d, J = 8.1 Hz, 2H), 7.5 (t, J = 12.5 Hz, 1H, CH=CH-NH), 9.4 (d, J = 12.7 Hz, 1H,
CH=CH-NH); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21l) δ 55.5 (s, OCH3), 55.7 (s, OCH3), 89.8, 114.8,
115.6, 117.52, 123.1, 125, 129, 129.3, 139.8, 141.5 (t, 3JCF = 3.9 Hz, CF2-(C=N)-CH=CH-NH), 151.1, 154.2
(t, 2JC1F = 29.6 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21l) δ −80.5 (m,
3F), −109 (m, 2F), −120.3 (m, 2F), −122.2 (m, 2F), −125.5 (m, 2F). MS (m/z): 551 [M + H]+. HRMS calcd.
for C22H18F11N2O2+: 551.1193, found: 551.1195; Anal calcd. for C22H17F11N2O2: C, 48.01; H, 3.11; N,
5.09, found C, 48.05; H, 3.12; N, 5.08.
3.7. General Procedure for the Isolation of 2-Perfluoropentyl- and 2-Trifluoromethyl-1-((2-/4-)-Carboxy-phenyl)
Amino-3-((2-/4-)-Carboxyphenyl)Iminopropene Intermediates 21m–n’
A mixture of one equivalent of gem-iodoacetate compounds 14 or 14’ and two equivalents of
the corresponding aminobenzoic acid 15m–n in dichloromethane (10 mL DCM for 1 g of 14–14’) was
stirred at reflux until disappearance of 19F-NMR signals corresponding to the starting products 14–14’
(2–4 h). The reaction mixture was concentrated in vacuo and then diluted with diethyl ether. An excess
of petroleum ether was added, and the precipitate that had formed was eliminated by vacuum
filtration. The filtrate was concentrated under reduced pressure to give brown oil. Chromatography
over silica gel column (eluent, petroleum ether/ethyl acetate 90/10 v/v) then purification over a plate
chromatography (eluent petroleum ether/ethyl acetate 70/30 v/v) yielded pure compounds 21m-n’ as
yellow amorphous solids.
3-Perfluoropentyl-1-(2-carboxyphenylamino)-3-(2-carboxyphenylimino)-propene (21m). 5.15 g of
2-aminobenzoic acid 15m (3.75 × 10−2 mol) were added to a solution of 10 g (1.87 × 10−2 mol)
of 14 (RF = C5F11) in 100 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux.
4.88 g of the title product 21m were obtained after column chromatography, yield 45%. 1H-NMR
(300.13 MHz, DMSO-d6, EEE-21m) δ 5.7 (d, 3JHH = 13.7 Hz, CH=CH-NH), 6.9–7.45 (m, 8H, HAr), 7.6
(m, 1H, CH=CH-NH), 9.6 (bs, 1H, CH=CH-NH), 14 (bs, 2H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6,
EEE-21m) δ 90.1, 114.5, 115, 118.1, 120.8, 129.1, 129.4, 131.2, 141.5, 150.5, 153.1 (t, 2JC1F = 25.6 Hz,
CF2-(C=N)-CH=CH-NH), 170.5 (s, CO2H), 170.7 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21m)
δ −80.3 (m, 3F), −109.68 (m, 2F), −120.4 (m, 2F), −121.05 (m, 2F), −125.83 (m, 2F). MS (m/z): 579 [M +
H]+. HRMS calcd. for C22H14F11N2O4+: 579.0778, found: 579.0783 Anal calcd. for: C22H13F11N2O4:
C, 45.69; H, 2.27; N, 4.84, found C, 45.72; H, 2.26; N,4.82.
3-Trifluoromethyl-1-(2-carboxyphenylamino)-3-(2-carboxyphenylimino)-propene (21m’). 6.44 g of
2-aminobenzoic acid 15m (4.69 × 10−2 mol) were added to a solution of 7.8 g (2.34 × 10−2 mol)
of 14’ (RF = CF3) in 78 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 3.99 g of
the title product 21m’ were obtained after column chromatography, yield 45%. 1H-NMR (300.13 MHz,
DMSO-d6, EEE-21m’) δ 5.7 (d, J = 13.6 Hz, CH=CH-NH), 6.8–7.5 (m, 8H, HAr), 7.6 (m, 1H, CH=CH-NH),
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9.7 (bs, 1H, CH=CH-NH), 14.1 (bs, 2H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21m’) δ 91.4,
115.2, 119.5, 121 (q, 1JCF = 277.7 Hz, CF3), 129.2, 129.7, 130.1, 130.8, 131.5, 132.5, 138.1, 140.7 (q, 3JCF =
2.8 Hz, CF3-(C=N)-CH=CH-NH), 147.1, 153.5 (q, 2JCF = 30.1 Hz, CF3-(C=N)-CH=CH-NH), 170.3 (s,
CO2H), 170.5 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21m’) δ −65.6 (s, 3F). MS (m/z): 379 [M
+ H]+. HRMS calcd. for C18H14F3N2O4+: 379.0906, found: 379.0911 Anal calcd. for: C18H13F3N2O4:
C, 57.15; H, 3.46; N, 7.41, found C, 57.19; H, 3.45; N,7.40.
3-Perfluoropenthyl-1-(4-carboxyphenyl)amino-3-(4-carboxyphenyl)iminopropene (21n). 5.15 g of
4-aminobenzoic acid (3.75 × 10−2 mole) were added to a solution of 10 g (1.87 × 10−2 mole) of
14 (R’F = C6F13) in 100 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 5.21
g of the title product 21n were obtained after column chromatography, yield 48%. 1H-NMR (300.13
MHz, DMSO-d6, EEE-21n) δ 5.4 (d, 3JHH = 12.9 Hz, 1H, CH=CH-NH), 6.8 (d, 3JHH = 8.1 Hz, 2H,
Ar-H), 7 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 7.3 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 7.4 (d, 3JHH = 8.1 Hz, 2H,
Ar-H), 7.6 (t (dd), 3JHH = 3JHNH = 12.5 Hz, 1H, CH=CH-NH), 9.9 (d, 3JHNH = 12.2 Hz, CH=CH-NH),
13.5 (bs, 2H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21n) δ 91, 115.5, 118.5, 121.9, 123.5, 129.2,
129.5, 130.1, 142.5, 141.9 (t, 3JCF = 4.9 Hz, CF2-(C=N)-CH=CH-NH), 149.8, 153.8 (t, 2JC1F = 20.5 Hz,
CF2-(C=N)-CH=CH-NH); 170.1 (s, CO2H), 170.4 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21n)
δ −80.5 (m, 3F, CF2-CF2-CF2-CF2-CF3), −109.2 (t, J = 11.2 Hz, 2F, CF2-CF2-CF2-CF2-CF3), −120.4 (m, 2F,
CF2-CF2-CF2-CF2-CF3), −121.5 (m, 2F, CF2-CF2-CF2-CF2-CF3), −125.5 (m, 2F, CF2-CF2-CF2-CF2-CF3).
MS (m/z): 579 [M + H]+. HRMS calcd. for C22H14F11N2O4+: 579.0778, found: 579.0782 Anal calcd. for:
C22H13F11N2O4: C, 45.69; H, 2.27; N, 4.84, found C, 45.71; H, 2.26; N,4.82.
3-Trifluoromethyl-1-(4-carboxyphenylamino)-3-(4-carboxyphenylimino)-propene (21n’). 8.67 g of
4-aminobenzoic acid 15n (6.32 × 10−2 mol) were added to a solution of 10.5 g (3.16 × 10−2 mol)
of 14 (RF = CF3) in 105 mL of dry dichloromethane. The mixture was stirred for 4 h at reflux. 6.57 g of
the title product 21n’ were obtained after column chromatography, yield 55%. 1H-NMR (300.13 MHz,
DMSO-d6, EEE-21n’) δ 5.5 (d, 3JHH = 13 Hz, 1H, CH=CH-NH), 6.8 (d, J = 8 Hz, 2H), 7.1 (d, J = 8.1 Hz,
2H), 7.3 (d, J = 8 Hz, 2H), 7.4 (d, J = 8.1 Hz, 2H), 7.6 (t, J = J = 12.8 Hz, 1H, CH=CH-NH), 9.8 (d,
J = 12.5 Hz, CH=CH-NH), 13.8 (bs, 2H, CO2H); 13C-NMR (75.46 MHz, DMSO-d6, EEE-21n’) δ 91.1,
115.5, 119.8, 121.5 (q, CF3, 1JCF = 278.2 Hz), 123.1, 123.5, 128.9, 129.2, 140.5, 141.2 (q, 3JCF = 2.1 Hz,
CF3-(C=N)-CH=CH-NH), 150.2, 153.5 (q, 2JCF = 27.5 Hz, CF3-(C=N)-CH=CH-NH), 170 (s, CO2H),
170.2 (s, CO2H); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21n’) δ −65.5 (s, 3F). MS (m/z): 379 [M + H]+.
HRMS calcd. for C18H14F3N2O4+: 379.0906, found: 379.0910 Anal calcd. for: C18H13F3N2O4: C, 57.15;
H, 3.46; N, 7.41, found C, 57.19; H, 3.45; N,7.42.
3.8. General Procedure for the Preparation and Isolation of 2-Perfluoropentyl- and 2-Trifluoromethyl-1-(3-
Methoxyphenyl)Amino-3-(3-Methoxyphenyl)Iminopropene Intermediates 21o–o’
A mixture of one equivalent of gem-iodoacetate compounds 14 or 14’ and two equivalents of
3-anisidine 15o in dichloromethane (20 mL DCM for 1 g of 14–14’) was stirred at room temperature.
The evolution of the reaction was monitored by TLC (eluent petroleum ether/ethyl acetate: 80/20 v/v),
and 19F-NMR spectroscopy of aliquots. After four h of stirring, a solution of 10% sodium thiosulfate
was added to the reaction mixture and the product was extracted three times with ether. The combined
extracts were washed two times with saturated sodium bicarbonate solution, dried over anhydrous
sodium sulfate and concentrated under reduced pressure to give a yellow oil. Chromatography
over silica gel column (eluent: petroleum ether/ethyl acetate 98/2 v/v), then purification over a plate
chromatography (eluent petroleum ether/ethyl acetate 85/15 v/v) yielded the pure compounds 21o–o’
as yellow liquids.
3-Perfluoropenthyl-1-(3-methoxyphenyl)amino-3-(3-methoxyphenyl)iminopropene (21o). 3.98 g of 3-anisidine
15o (3.23 × 10−2 mole) were added to a solution of 8.6 g (1.61 × 10−2 mole) of 14 (RF = C5F11) in 172
mL of dry dichloromethane. 4 g of the title product 21o were obtained after column chromatography,
yield 45%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21o) δ 3.7 (s, 3H, OCH3), 3.8 (s, 3H, OCH3), 5.4 (d,
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J = 13.1 Hz, 1H, CH=CH-NH), 6.6–6.9 (m, 6H, Ph-H), 7.1 (t, J = 7.4 Hz, 1H, Ph-H), 7.3 (t, J = 7.4 Hz,
1H, Ph-H), 7.6 (t, J = 12.9 Hz, 1H, CH=CH-NH), 9.6 (d, J = 12.8 Hz, 1H, CH=CH-NH); 13C-NMR
(75.46 MHz, DMSO-d6, EEE-21o) δ 55.5 (s, OCH3), 55.6 (s, OCH3), 89.5, 113.5, 115.5, 117.5, 121.5,
123.5, 129.1, 129.4, 130.6, 140, 140.8 (t, 3JCF = 4.2 Hz, CF2-(C=N)-CH=CH-NH), 150.5, 153.2 (t, 2JC1F
= 26.7 Hz, CF2-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21o) δ −80.5 (m, 3F,
CF2-CF2-CF2-CF2-CF3), −109.5 (m, 2F, CF2-CF2-CF2-CF2-CF3), −120.5 (m, 2F, CF2-CF2-CF2-CF2-CF3),
−121.3 (m, 2F, CF2-CF2-CF2-CF2-CF3), −125.6 (m, 2F, CF2-CF2-CF2-CF2-CF3). MS (m/z): 551 [M + H]+.
HRMS calcd. for C22H18F11N2O2+: 551.1193, found: 551.1198; Anal calcd. for C22H17F11N2O2: C,
48.01; H, 3.11; N, 5.09, found C, 48.03; H, 3.11; N, 5.10.
3-Trifluoromethyl-1-(3-methoxyphenyl)amino-3-(3-methoxyphenyl)iminopropene (21o’). 6.67 g of 3-anisidine
15o (5.42 × 10−2 mol) were added to a solution of 9 g (2.71 × 10−2 mol) of 14’ (RF = CF3) in 180 mL of
dry dichloromethane. 4.55 g of the title product 21o’ were obtained after column chromatography,
yield 48%. 1H-NMR (300.13 MHz, DMSO-d6, EEE-21o’) δ 3.7 (s, 3H, OCH3), 3.8 (s, 3H, OCH3), 5.4 (d,
J = 13 Hz, 1H, CH=CH-NH), 6.7–6.9 (m, 6H, Ph-H), 7.1 (t, J = 7.3 Hz, 1H, Ph-H), 7.3 (t, J = 7.4 Hz, 1H,
Ph-H), 7.7 (t, J = 12.7 Hz, 1H, CH=CH-NH), 9.6 (d, J = 12.6 Hz, 1H, CH=CH-NH); 13C-NMR (75.46
MHz, DMSO-d6, EEE-21o’) δ 55.5 (s, OCH3), 55.6 (s, OCH3), 90.2, 113.1, 115.5, 116.5, 119.4, 120.7 (q, 1JCF
= 278.7 Hz, CF3), 123.5, 124.2, 129.6, 138.7, 139.1, 140.5, 141 (q, 3JCF = 2.8 Hz, CF3-(C=N)-CH=CH-NH),
149.6, 153.5 (q, 2JCF = 30.1 Hz, CF3-(C=N)-CH=CH-NH); 19F-NMR (282.4 MHz, DMSO-d6, EEE-21o’)
δ −65.6 (s, 3F, CF3). MS (m/z): 351 [M + H]+. HRMS calcd. for C18H18F3N2O2+: 351.1320, found:
351.1322; Anal calcd. for C18H17F3N2O2: C, 61.71; H, 4.89; N, 8.00, found C, 61.75; H, 4.88; N, 8.01.
3.9. Reaction of N,N’-Diaryl-2-(Perfluoroalkyl)-1,5-Diazapentadienes 21a–o’ with Anilines 15a–o and Ketones
16t–v: Formation of 2-Trifluoromethyl-/2-Perfluoroalkyl-N-Arylpyridinium Derivatives 17–19 or
2-Trifluoromethyl-/2-Perfluoroalkyl-7-Methoxyquinolines 20o–o’
To a stirred solution of N,N’-diaryl-2-(perfluoroalkyl)-1.5-diazapentadienes 21a–o’ (1 equiv.) in
anhydrous dichloromethane (10 mL DCM for 1g of 21), was added one equiv. of the corresponding
substituted aniline 15a–o and 1.2 equiv. of ketone 16t–v. The mixture was stirred under reflux for
desired time (4–12 h) until complete consumption of 21a–o’ (monitored by TLC eluent petroleum
ether/ethyl acetate: 80/20 v/v, and 19F-NMR of aliquots). When the reaction was completed, the mixture
was allowed to cool to r.t. then the brown precipitate accumulated during the reaction was separated
by vacuum filtration (it was subsequently identified as anilinium salts by NMR and MS).
Then in the cases of pyridinium iodides 17a–l, 18a–l and 19a–l, ethyl ether was added to the filtrate.
However, in the cases of pyridinium iodides 17m–n’, 18m–n and 19m, a mixture of petroleum ether and
ethyl ether (40/60 v/v) was added to the corresponding filtrates and the expected pyridiniums 17a–n’,
18a–n and 19a–m precipitate instantly and were isolated by vacuum filtration as amorphous solids.
In the case of 3-anisidine (15o) at the end of the reaction, the mixture was concentrated under
reduced pressure and then stirred with diethyl ether. An excess of petroleum ether was added;
the precipitate that had formed was eliminated by vacuum filtration and washed three times with
petroleum ether. The filtrate was concentrated in vacuo to give a yellow oil. Chromatography over
silica gel column (eluent, petroleum ether/ethyl acetate 98/2 v/v) left a yellow oil which was crystallized
from methanol/water to give pure samples of the corresponding quinolines 20o–o’. All the isolated
pyridiniums 17a–n’, 18a–n, 19a–m and quinolines 20o–o’ were fully characterized and found identical
to the previously obtained products.
4. Conclusions
We have developed a new simple and efficient method for the synthesis
of substituted 2-trifluoromethyl-/2-perfluoroalkyl-N-arylpyridiniums 17a–n’,
2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-5,6,7,8-tetrahydroquinoliniums 18a–n and
2-trifluoromethyl-/2-perfluoroalkyl-N-(R-phenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridiniums
19a–m, starting from perfluoroalkylated gem-iodoacetoxy derivative 14–14”, substituted anilines 15a–o
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and ketones 16t–v, under mild conditions with good to excellent yields. To our knowledge this is
the first synthesis of pyridinium derivatives by a multicomponent reaction involving an activated
β-dicarbonyl compound, a ketone, and an aromatic amine.
The reaction is assumed to proceed by a cascade cyclisation mechanism [66–70], either through an
inverse electron demand Diels-Alder (IEDDA) cycloaddition, or through an Aza-Robinson cyclisation
(Scheme 7), both ways being supported by the isolation and characterization of the intermediate
N,N’-diaryl-2-(perfluoroalkyl)-1,5-diazapentadiene 21a–o’, while stereoelectronic effects may account
for the preferred intramolecular diazapentadiene cyclization in the case of the m-methoxy substituent,
selectively forming the perfluoroalkylated quinoline 20.
Beyond the scope of this work, various literature reports point out such hetero-Diels-Alder
reactions as possibly relevant of bio-orthogonal chemistry because of their selectivity, moderate
activation energy and ability to proceed under biological conditions, taking in account e.g., the pH
and temperature [66–70]. Besides, since pyridinium-containing compounds are considered as possible
exogenous neurotoxins, research efforts have also been undertaken to disclose the formation of such
compounds under endogenous (biogenic) conditions [33–37,43–45]. In this respect, the biological
activity of newly synthesized pyridinium compounds 17–19, are currently under evaluation with
promising results to be published in future papers.
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